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Abstract
The enzyme 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase
(DAH7PS) catalyses the first reaction in the shikimate pathway, leading
to the biosynthesis of aromatic compounds including the aromatic amino
acids. The catalytic activity of DAH7PS is regulated through feedback
inhibition and is the major control point for the pathway. DAH7PSs are
divided into two families, type I and type II, based on molecular weight
and amino acid sequence. Type I DAH7PSs can be further divided based
on sequence similarity. All DAH7PS enzymes with their crystal structures
solved share a basic (β/α)8-barrel fold in which the key catalytic components
are housed. Furthermore, all structurally characterised DAH7PSs, except
Pyrococcus furiosus DAH7PS (PfuDAH7PS) and Aeropyrum pernix DAH7PS,
have recruited extra structural motifs that are implicated in allosteric
regulation. However, there are significant differences in the additional
structural elements.
This thesis investigates the hypothesis that the diverse regulation strat-
egies for controlling DAH7PS activity have evolved by domain recruitment,
whereby regulatory domains have been added to the catalytic barrel.
Chapter 2 describes the functional characterisation of the type Iβ Ther-
motoga maritima DAH7PS (TmaDAH7PS), and the exploration of its response
to inhibitors. The catalytic activity of TmaDAH7PS was found to be sub-
stantially inhibited by tyrosine (Tyr) and to a lesser extent, phenylalanine
(Phe). The putative regulatory domain previously identified as a ferredoxin-
like domain was recognised as an aspartate kinase-chorismate-mutase-tyrA
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Variation of the structural elements decorating the basic barrel structure of
the DAH7PS enzymes. (a) Pyrococcus furiosis DAH7PS, (b) Thermotoga mari-
tima DAH7PS, (c) Escherichia coli DAH7PS and (d) Mycobacterium tuberculosis
DAH7PS.
(prephenate dehydrogenase) or ACT domain.
Chapter 3 describes the characterisation of TmaDAH7PS with the N-
terminal domain removed. The truncated enzyme was found to be more
catalytically active than wild-type TmaDAH7PS and insensitive to inhibition
by the aromatic amino acids, Tyr, Phe and tryptophan. Apart from the
truncation of the ACT domain, the crystal structure of truncTmaDAH7PS
showed no major changes to the monomer structure when compared to wild-
type TmaDAH7PS. However, truncTmaDAH7PS crystallises as a dimer, unlike
wild-type TmaDAH7PS.
In Chapter 4, the solution of the crystal structure of TmaDAH7PS
with Tyr bound is presented. Tyr binding was shown to induce a significant
conformational change, and Tyr is observed to bind at the interface between
the ACT domains from two diagonally located monomers of the tetramer.
vThe major reorganisation of the regulatory domain with respect to the bar-
rel observed in the crystal structure, was confirmed by small angle X-ray
scattering. The closed conformation adopted by the protein on Tyr binding
physically gates the neighbouring barrel and blocks substrate entry into the
active site.
Chapter 5 explores the interactions between TmaDAH7PS and the
allosteric inhibitor, Tyr. The residues His29 and Ser31, which form hydrogen
bonds with the hydroxyl moiety of the Tyr ligand, were examined for their
impact on the sensitivity and selectivity of the enzyme for the inhibitors Tyr
and Phe. The hydroxyl side chain of Ser31 was found to be important for both
the preferential inhibition by Tyr over Phe and the inhibitory mechanism.
His29 (the hydrogen-bonding partner of Ser31) appears to play a secondary
role in determining ligand selectivity and the relative positioning of these two
residues is crucial to the inhibition of the enzyme.
Chapter 6 evaluates the transferability of allosteric control of catalytic
activity. The ACT domain of TmaDAH7PS was fused onto the barrel of the
unregulated PfuDAH7PS. This chimeric enzyme was found to be catalytically
active, inhibited by Tyr (although less sensitive) and preliminary crystallo-
graphic results show inhibition occurs via the same conformational change
observed for wild-type TmaDAH7PS.
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1Chapter 1
Introduction
1.1 The Shikimate Pathway
Organisms differ in their capability to carry out the chemical reactions
required to produce the amino acids, the constituents of proteins. Most
microorganisms are proficient in all such biosyntheses, whereas animals are
able to manufacture approximately only half of the amino acids. Among the
amino acids that cannot be biosynthesised by animals are the three aromatic
amino acids, tyrosine (Tyr), phenylalanine (Phe) and tryptophan (Trp). In
microorganisms and plants these important compounds are produced via the
shikimate pathway.1,2
The shikimate pathway is a series of seven enzyme-catalysed reactions
(Figure 1.1) responsible for the biosynthesis of chorismate, the precursor for
many important aromatic compounds. Branching of the shikimate pathway
occurs after the formation of chorismate (derived from the Greek term meaning
“fork”), where one branch leads to anthranilate and thereon to Trp, and the
other branch leads to prephenate, which is a precursor for both Tyr and
Phe. Further branch points lead to the formation of other aromatic and
pre-aromatic compounds including various quinones, folic acid and vitamins
E and K.3
2Figure 1.1: Overview of the seven enzyme-catalysed reactions of the shikimate
pathway leading to chorismate before the pathway branches to form important
aromatic compounds. The reaction catalysed by DAH7PS is coloured blue.
3The shikimate pathway operates in bacteria, plants and fungi and has
more recently been shown to operate in apicomplexan parasites.4 As the
pathway is absent in mammals, considerable interest has been expressed in
the pathway as a possible target for antimicrobial agents and herbicides.5
Successful inhibition of the shikimate pathway has been demonstrated by the
broad-spectrum herbicide glyphosate, which inhibits the sixth enzyme of the
pathway, 5-enolpyruvyl shikimate 3-phosphate synthase (EPSPS).6,7
1.1.1 Discovery of the Shikimate Pathway
Shikimic acid was the first intermediate of the shikimate pathway (Figure
1.1) to be discovered and was first isolated from Illicium religiosum,8 the
Japanese name shikimi-no-ki (anise tree) of which the shikimate pathway
draws its name.9 It was not until the 1950s when Davis1 obtained a series
of E. coli mutants that could only grow by supplementation with aromatic
substances, that shikimate, due to its accumulation, was implicated as an
intermediate in the biosynthesis of the aromatic amino acids and other essential
substances.10,11 The other intermediates of the pathway were elucidated using
ultra-violet (UV)-light induced mutants of E. coli, Aerobacter aerogenes and
Neurospora.2,12–16 Isotope tracer experiments using 14C-d-glucose showed that
shikimic acid is derived from phosphoenolpyruvate (PEP), a three-carbon
product from glycolysis, and the remaining four carbons from erythrose
4-phosphate (E4P) provided by the pentose phosphate pathway.17
1.2 Introduction to
3-Deoxy-D-arabino-heptulosonate
7-phosphate Synthase
The first enzyme of the shikimate pathway is 3-deoxy-d-arabino-heptulo-
sonate 7-phosphate synthase (DAH7PS) (EC 2.5.1.54), which catalyses an
4aldol-like condensation reaction between the pentose phosphate pathway
intermediate, E4P and the glycolytic intermediate, PEP.18 This generates 3-
deoxy-d-arabino-heptulosonate 7-phosphate (DAH7P), a seven-carbon sugar,
with the release of inorganic phosphate (Pi) (Figures 1.1 and 1.2).
Figure 1.2: Condensation of PEP with phosphorylated monosaccharides.
Regulation of the catalytic activity of DAH7PS has been shown to be an
important mechanism for control of cellular levels of aromatic compounds in
microorganisms and plants.19 The overall flux through the shikimate pathway
is controlled via inhibition of DAH7PS, usually mediated by the end products
of the pathway, the aromatic amino acids.20
Other enzymes found at branch points throughout the shikimate path-
way are also inhibited by the pathway end products. In B. subtilis, prephenate
5dehydratase, prephenate dehydrogenase and anthranilate synthetase, rather
than DAH7PS, are reported to be inhibited by Phe, Tyr and Trp respect-
ively.21,22 B. subtilis DAH7PS (BsuDAH7PS) itself, is feedback regulated by
chorismate.23
1.2.1 Classification of DAH7PSs
DAH7PSs from different species can be divided into two distinct homologous
families based on their molecular weight and amino acid sequence. These
families have been referred to as type I and II according to the notation of
Jensen.24 The type I family of DAH7PSs can be further divided into type Iα
and Iβ subfamilies based solely on sequence similarity.
The first and most extensively studied group of DAH7PS enzymes
belong to the type Iα subfamily, and this group includes the well-characterised
enzymes from E. coli 25–32 and S. cerevisiae.33,34 With molecular masses below
40 kDa, the type I DAH7PSs are smaller than their type II orthologues.
The levels of overall sequence identity between individual members of the
type Iα and type Iβ subfamilies are relatively low (approximately 18 percent),
suggesting little homology between the two subfamilies.35 Enzymes belonging
to the type Iβ DAH7PS subfamily are generally smaller than their type Iα
counterparts (30 kDa to 38 kDa in comparison to approximately 40 kDa) and
are more closely related in sequence to the 3-deoxy-d-manno-octulosonate
8-phosphate synthase (KDO8PS) enzymes (denoted class IβK) than the type
Iα subfamily (Figure 1.3).24
KDO8PS catalyses a reaction analogous to that catalysed by DAH7PS,
condensing PEP with a five-carbon sugar, arabinose 5-phosphate (A5P), to
form 3-deoxy-d-manno-octulosonate 8-phosphate (KDO8P) and inorganic
phosphate (Figure 1.2). The reaction catalysed by KDO8PS is the first com-
mitted step in the formation of 3-deoxy-d-manno-2-octulosonic acid (KDO),
an essential component of the lipopolysaccharide layer in the cell walls of
Gram-negative bacteria. Formation of the lipopolysaccharide layer is import-
6Figure 1.3: Phylogenetic homology analysis, modified from Jensen24 comparing
Iα and Iβ enzymes. The Iα DAH7PS enzymes are feedback regulated. The Iβ
subfamily encompasses the type Iβ DAH7PS (IβD) (both regulated (TmaDAH7PS)
and unregulated (PfuDAH7PS)), and the closely related KDO8PS enzymes (IβK).
The hypothetical ancestral root is denoted by a white circle.
7ant for both growth and virulence of Gram-negative bacteria, identifying
KDO8PS as a possible target for anti-bacterial drug design.36,37
Despite the lack of overall sequence similarity between the Iα, IβD and
IβK enzymes, multiple sequence alignments indicate that they comprise a
family of homologues that share a number of conserved residues,35 suggesting
common evolutionary ancestry. This relationship has been further cemented
by the determination of several crystal structures of type Iα and Iβ DAH7PSs,
and KDO8PSs, which show that all three groups of enzymes are structurally
similar (refer to section 1.2.4).25,34,38–40
Type II DAH7PSs, with a molecular weight of approximately 54 kDa, are
larger than their type I orthologues and were originally found in higher plants
where they were thought to function in aromatic secondary metabolism.9,41
A limited number of microbial enzymes were believed to exist within this
family. However, as more microbial genes have been sequenced, evidence
suggests that the type II DAH7PS family actually consists of a small set of
plant enzymes within a diverse set of microbial enzymes.42 A small number
of organisms have been found to contain both type I and type II enzymes
including Xanthomonas campestris, Pseudomonas aeruginosa, Stigmatella
aurantiaca, Amycolatopsis methanolica and Amycolatopsis mediterranei 43,44
and several of the type II DAH7PSs from these organisms have been shown
to be required for the biosynthesis of specific secondary metabolites.44,45
Evidence that type II DAH7PSs function in aromatic amino acid biosynthesis
and therefore primary metabolism, results from the presence of only type II
enzymes in a number of species including Helicobacter pylori, Streptomyces,
Corynebacterium diphtheriae, Novosphingobium aromaticivorans and several
Mycobacteria.
Microbial type II enzymes share less than ten percent amino acid
sequence identity with the type I enzymes. However, structural information
(as discussed in section 1.2.5) reveals similar order and spacing of active-site
residues between the type I and type II enzymes.46,47
81.2.2 Catalytic Mechanism
The reaction mechanism of DAH7PS has been subject to extensive structural
and kinetic studies and many of the key details have been elucidated (Figure
1.4).26,27,34,48–50 Analysis of the product formed when using deuterated PEP as
a substrate shows the reaction proceeds in a stereospecific manner, where the
si face of the alkene functionality of PEP attacks the re face of the aldehyde
group of E4P.51 Unusually, rather than utilising the high energy contained
in the phosphate ester bond (∆G◦ of −62 kJ mol−1) by cleavage of the P-O
bond of PEP,52 DAH7PS cleaves the C-O bond of PEP.5 This requires that
water must act as a nucleophile at C2 of PEP at some stage of the reaction.
Early studies using E. coli DAH7PS (EcoDAH7PS) indicated that a
ping-pong mechanism may operate in DAH7PS during catalysis.53 Later
kinetic studies using lower concentrations of substrates and more highly
Figure 1.4: Proposed mechanism of condensation of PEP with E4P catalysed by
DAH7PS.
9purified enzyme are consistent with the reaction proceeding via an ordered
sequential mechanism, where PEP binds to the enzyme first, followed by E4P,
phosphate release, and finally DAH7P release.50
The first step of the reaction is thought to be initiated by the C3 of
PEP attacking C1 of E4P, which is activated by coordination of the carbonyl
group of E4P to an essential divalent metal ion. This addition step of the
reaction occurs in a stereospecific manner and the resulting oxocarbenium ion
is then attacked by water, producing a bisphosphate hemiketal intermediate.
This tetrahedral intermediate then undergoes C-O bond cleavage, releasing
phosphate and forming the C2 carbonyl of DAH7P. The product is thought
to be released from the enzyme before formation of the more stable cyclic
pyranose form.54
1.2.3 Metal Activation
Unlike the related KDO8PS enzymes, which can be metal dependent or metal
independent, all DAH7PS enzymes that have been characterised to date are
metal dependent. A variety of divalent metal ions have been proposed to reside
in the active site under physiological conditions including iron,55,56 cobalt30,57
and copper.58 Some DAH7PS enzymes are reported to be inactivated by the
addition of a metal chelator, such as ethylenediaminetetraacetic acid (EDTA),
with restoration of catalytic activity occurring with addition of a divalent
metal ion.30,58–61 On the contrary, other DAH7PS enzymes have been shown
to be unaffected by EDTA or are unable to be reactivated by addition of
excess metal ions.28,29,62
Generally, DAH7PS enzymes can be activated by a number of different
divalent metal ions including Mn2+, Cd2+, Co2+, Cu2+, Zn2+ and Fe2+. The
variation within the metal-activation series does not appear to correlate with
the subfamily of DAH7PS and although the exact identity of the metal ion
remains undefined, it is likely to be dependent on bioavailability.
Two roles have been proposed for the metal ion. The most likely role is
10
Figure 1.5: The two possible roles for the metal ion in DAH7PS.
as a Lewis acid, in which the metal functions to encourage attack of E4P by
PEP by withdrawing electron density from the E4P carbonyl group (Figure
1.5). The alternative role is that the metal ion reduces the pKa of the
nucleophilic water through coordination so as to provide a hydroxide ion for
the attack at C2 of PEP. In this mechanism, C-O bond formation at C2 of
PEP would precede C-C bond formation between PEP and E4P, and the
reaction would proceed via a carbanion intermediate or transition state with
carbanion character at C3 of PEP.
There are a number of problems associated with this alternative car-
banion mechanism. Firstly, in order for hydroxide to attack, C2 of PEP
requires unprecedented electrophilic character.63 In addition, this mechanism
requires the presence of a resonance unstabilised carbanion that would likely
be quenched by hydrogen abstraction from another species within the imme-
diate environment, such as water or the carboxylate or ammonium containing
side chains of the protein itself.
1.2.4 Structure of DAH7PSs
Type Iα DAH7PSs
The most well characterised examples of DAH7PSs are those from E. coli. The
genome of E. coli encodes three isozymes of DAH7PS, which are all members
of the Iα subfamily. These enzymes are all approximately the same molecular
11
weight (approximately 38 kDa) and are similar in sequence.25 However, each
isozyme is specifically inhibited by one of the aromatic amino acids.
The Phe-sensitive EcoDAH7PS, EcoDAH7PS(Phe), was the first struc-
ture of a DAH7PS to be solved by X-ray crystallography.25 This structure,
and subsequent structural studies of other DAH7PSs,34,38,40,46,47,64 show that
the tertiary structure of all DAH7PS enzymes is comprised of a (β/α)8 or
triosephosphate isomerase (TIM)-barrel monomer fold,27 a common fold for
globular proteins. As is typical for TIM-barrel enzymes, the active site of
DAH7PS is located at the C-terminal end of the barrel.65 The loops connect-
ing helices and strands located at the N-terminal end of the barrel (α-β loops)
are shorter than the loops at the C-terminal end of the barrel (β-α loops).
These extended loops provide the residues that form the active site.
The EcoDAH7PS(Phe) crystal structure also reveals the enhancement
of the core barrel catalytic domain with an N-terminal extension (strand β0
followed by two helices α00 and α0), and an internal β6a/β6b sheet inserted
before the β6 strand of the barrel (Figure 1.6).25 Both of these extensions are
located outside the core barrel and are implicated in the allosteric inhibition
of the enzyme.32,33
EcoDAH7PS(Phe) crystallises as a tetramer, consisting of a dimer of
two tight dimers (Figure 1.7). Within the dimers, the formation of an
intermolecular β-sheet involving the N-terminal β0 strand of one monomer
with the βa-βb strands of a neighbouring subunit, enhances the association.25
S. cerevisiae expresses two isozymes of DAH7PS, which are also cat-
egorised into the type Iα subfamily of DAH7PS enzymes. As for the Eco-
DAH7PS(Phe) enzyme, the Tyr-repressible isozyme, S. cerevisiae DAH7PS
(SceDAH7PS)(Tyr), also crystallises as a tetramer. Despite originating from
different organisms, EcoDAH7PS(Phe) and SceDAH7PS(Tyr) are very sim-
ilar enzymes in terms of sequence (two-hundred conserved residues) and
of monomer folds (root-mean-square deviation (RMSD) of 0.6Å between
equivalent Cα atoms) (Figure 1.6).
Although one of the two dimers between EcoDAH7PS(Phe) and Sce-
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Figure 1.6: Comparison of the monomeric structure of EcoDAH7PS (PDB code
1KFL) and SceDAH7PS (PDB code 1HFB). The core barrel is coloured blue and
N-terminal and internal extensions are coloured red and yellow, respectively.
(a) (b)
Figure 1.7: Superposition of the tetrameric structure of EcoDAH7PS (PDB code
1KFL) coloured blue and SceDAH7PS (PDB code 1HFB) coloured green.
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DAH7PS(Tyr) is essentially superimposable (Figure 1.6), the interfaces that
form the tetramers are slightly twisted relative to each other (Figure 1.7).
Furthermore, in SceDAH7PS(Tyr) the tetrameric association is purely hydro-
phobic whereas electrostatic and hydrogen-bonding interactions play a more
important role in EcoDAH7PS(Phe). Regardless of these subtle differences,
the type Iα subfamily of DAH7PS appear to be defined by the similarity of
extensions and insertions to the core barrel.
Type Iβ DAH7PSs
The first Iβ DAH7PS crystal structure solved was of T. maritima DAH7PS
(TmaDAH7PS) (Figure 1.8a).39 Again, the structure incorporates a core
(β/α)8 barrel, and besides the eight strands and helices that form the barrel,
the monomer units include a two-stranded antiparallel β-hairpin that covers
the N-terminal end of the barrel. The core barrel structure is connected at
the N terminus via a linker to another compact domain. The extra domain,
with a distinctive βαββαβ fold, is described as a ferredoxin-like (FL) domain.
It was speculated that this FL domain is involved in the feedback regulation
(a) (b)
Figure 1.8: Monomeric structure of (a) TmaDAH7PS (PDB code 1RZM) and
(b) PfuDAH7PS (PDB code 1ZCO) with the core barrels coloured in blue and the
N-terminal extensions in red.
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of TmaDAH7PS.39
The crystal structure of TmaDAH7PS shows that two dimers associate
to form a tetramer by extensive interactions between the (β/α)8 barrels. The
segments of the barrel involved in tetramer formation are helices α5–α8 and
loops β5-α5, β6-α6 and β7-α7. The FL domains and barrels do not interact
other than through their direct linkages and do not participate in the contacts
between subunits.
A common dimeric unit is shared between the type Iα and type Iβ
subfamilies of the DAH7PSs. However, although both subfamilies crystallise as
tetramers, the tetramers are formed by utilising completely different structural
elements.25,34,39,48 This means that although dimers can be superimposed, the
Figure 1.9: Superposition of the type Iα EcoDAH7PS (PDB code 1GG1), in blue,
onto the type Iβ PfuDAH7PS (PDB code 1ZCO), in cyan.
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tetramers cannot (Figure 1.9).
Resembling TmaDAH7PS, P. furiosus DAH7PS (PfuDAH7PS) (another
type Iβ DAH7PS) consists of a (β/α)8 barrel with the N-terminal end of the
barrel closed off by a two-stranded β-hairpin (Figure 1.8b).48 This enzyme
has no extra structural elements, meaning the monomer unit is composed of
only the core catalytic barrel. Regardless of this difference, PfuDAH7PS and
TmaDAH7PS share the same tetramer structure in the crystalline form.
The crystal structure of A. pernix DAH7PS (ApeDAH7PS) has been
solved and its molecular description was recently published.40 ApeDAH7PS
shares a similar unembellished barrel structure to PfuDAH7PS and forms
the same tetramer structure as both PfuDAH7PS and TmaDAH7PS in the
crystalline form.
Type II DAH7PSs
Of the type II family, only the M. tuberculosis DAH7PS (MtuDAH7PS)
crystal structure has been solved. Prior to this structure, it was unclear
whether the type II enzymes would be structurally related to the other
DAH7PSs. The MtuDAH7PS monomer shares the same core-barrel fold as
all other structurally characterised DAH7PS enzymes (Figure 1.10).46 Two
major additions decorate the barrel that are quite distinct from the additions
to the type Iα and type Iβ enzymes. An N-terminal extension comprises of
a β-strand followed by three helices (α0a, α0b, and α0c), the last of which
closes off the N-terminal end of the barrel. The other addition is formed by
two helices (α2a and α2b), which extend the α2-β3 connecting loop and pack
against the outside of the barrel. Again, these extensions are implicated in
allostery of the enzyme.66
Although comparison of the core barrel units of MtuDAH7PS and the
type Iα DAH7PSs suggest the same spatial arrangement of active-site residues,
the quaternary structure of MtuDAH7PS is distinct. The tetramer structure
of MtuDAH7PS is composed of two tightly associated dimers, however neither
16
Figure 1.10: Monomeric structure of the type II MtuDAH7PS (PDB code 3NUD).
The core barrel is coloured blue, N-terminal extension red and the internal extension
yellow.
Figure 1.11: Comparison of the quaternary structures of DAH7PS enzymes.
Superposition of the type II MtuDAH7PS tetramer (pink), onto the type Iα
EcoDAH7PS (cyan) and type Iβ PfuDAH7PS (blue).
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the dimer nor the monomer-monomer interface shares any commonality with
any subunit interface found in other DAH7PS structures (Figure 1.11).
1.2.5 Architecture of the Active Site
Despite the low overall sequence similarity between the type Iα, Iβ and type
II DAH7PS enzymes, both the identity and positioning of several key residues
involved in the catalytic activity of these enzymes are absolutely conserved
(Figure 1.12).
Figure 1.12: Side-on view of the architecture of the DAH7PS active site as
illustrated by EcoDAH7PS(Phe) (PDB code 1N8F). The β-strands and α-helices
belonging to the barrel are coloured light blue and blue, respectively. Non-barrel
regions (cyan), PEP (carbon atoms are coloured cyan), manganese (magenta sphere)
and a sulfate ion (yellow sticks) are indicated. The sulfate ion can be taken as an
estimated position of the phosphate group of E4P. Protein residues established for
ligand and metal binding are coloured yellow.
Metal Binding Site
All DAH7PSs require a divalent metal ion for catalytic activity. The metal
co-ordination site is located near the C-terminal end of the barrel25 and
residues contributing to the co-ordination of the metal ion are absolutely
18
conserved across all DAH7PS families. In the structure of EcoDAH7PS, the
metal ion, Mn2+, is held in a distorted bi-pyramidal geometry, coordinated to
the enzyme via residues positioned on the short loops β1-α1 (Cys61), β7-α7
(His268), strand β8 (Glu302) and on the long loop β8-α8 (Asp326) (Figure
1.13).
Figure 1.13: Overlay of the metal binding sites of EcoDAH7PS (PDB code 1N8F),
coloured cyan and SceDAH7PS (PDB code 1OF6), coloured blue. The metal ion
and water molecule are shown as a purple and red sphere respectively.
PEP Binding Site
The PEP binding site provides a series of non-covalent interactions between
the enzyme and PEP phosphate and carboxylate groups (Figure 1.14).27,34
PEP is positioned in the active site with hydrogen-bonding and salt-bridge
interactions mediated by three arginine (Arg) and two lysine (Lys) residues
(EcoDAH7PS numbering Arg165, Lys196, Lys97, Arg92 and Arg234), all of
which are conserved across all DAH7PS families.
E4P Binding Site
An absolutely conserved KPR(T/S) (EcoDAH7PS numbering Lys97, Pro98,
Arg99, Thr100) motif is found across all DAH7PS enzymes and forms a
19
Figure 1.14: PEP binding site of EcoDAH7PS(Phe) (PDB code 1N8F). Dashed
lines indicate hydrogen-bonding and salt-bridge interactions between PEP and the
surrounding water molecules and protein residues.
Figure 1.15: The binding site of E4P as modelled into the active site of
PfuDAH7PS.48 E4P is shown as yellow sticks, PEP as cyan sticks and the metal
ion, Mn2+, as a purple sphere.
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binding pocket for the enzyme’s second substrate, E4P.
The crystal structure of TmaDAH7PS was solved in complex with all
required reaction components, Cd2+, PEP and E4P.39 The presence of the two
substrates was observed due to the slow catalysis by the hyperthermophilic
enzyme at low temperatures. However, E4P was located at a site distant
to PEP where the reaction is not feasible. While no plausible structures of
enzyme-PEP-E4P complexes exist, the structure of SceDAH7PS has been
determined to high resolution with metal ion (Co2+), PEP and glycerol 3-
phosphate (G3P) bound.34 Information from this structure has been used to
infer the binding site of E4P, and also to model E4P into the active site of
PfuDAH7PS (Figure 1.15).48
Some DAH7PS enzymes are tolerant to the substitution of E4P with
alternative aldehydes, with deoxy and five-carbon phosphorylated substrates
being accepted as alternatives. The type Iβ enzymes show the greatest
substrate promiscuity.23,47,48,64,67–70
1.3 Enzyme Regulation
1.3.1 Introduction
Acting in sequence, enzymes form metabolic pathways by which nutrient
molecules are degraded, energy is released and is converted into useful, us-
able forms, and precursors are used and transformed into the thousands of
distinctive biomolecules found to exist in a living cell at any one time.71–73
Situated at key junctions are regulatory enzymes, which are able to sense the
metabolic needs of the cell and adjust their catalytic activity accordingly.74
The response of these enzymes ensures the integration of the diverse and
divergent metabolic activities of the cell.
Metabolic pathways can be controlled at three levels, namely by the
amount of enzymes available, and through modulation of enzyme activity and
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substrate availability. Therefore, there are a number of different mechanisms
governing the rates of enzyme catalysis including the control of transcription
of deoxyribonucleic acid (DNA) and translation into protein, compartmental-
isation,75 post-translational modifications,76 localisation77 and allostery.78
1.3.2 Transcriptional Regulation
Although the major mechanism for regulation of DAH7PS activity is via
feedback inhibition and the direct control of this enzyme’s catalytic activity,
other regulatory methods are also utilised. The three isozymes of Eco-
DAH7PS are also regulated through repression of transcriptional activity.
The expression of genes encoding for EcoDAH7PS(Phe) (aroG) and Eco-
DAH7PS(Tyr) (aroF), appear to be controlled by the Tyr repressor, tyrR
gene product,79,80 when in combination with Phe and Tyr respectively.81
The regulation of the expression of aroH, the structural gene for the
Trp-sensitive isozyme of EcoDAH7PS, EcoDAH7PS(Trp), is subject to control
by the Trp repressor, trpR and by Trp itself.82,83 When intracellular levels
of Trp are low, the Trp repressor exists predominantly in a dissociated or
aporepressor form (free of bound corepressor), which has a low affinity for the
operator DNA.84 However, when the level of Trp is elevated, due to increased
biosynthesis or transport, the aporepressor form of the Trp repressor binds to
its corepressor, Trp, to form an active repressor complex. This complex then
binds the respective operator DNAs to repress Trp, trpR and aroH operon
expression.82 In vitro DNA binding experiments have shown that the Trp
repressor binds at a regulatory site upstream of the aroH gene, preventing
transcription of the aroH gene by interfering with polymerase binding.82,83
1.3.3 Allostery
The allosteric regulation of DAH7PS is one of the major mechanisms for
control of the shikimate pathway.20 In a general sense, allostery can be defined
as the phenomenon where the activity or function of one part of a protein
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is effected and affected by a binding event at a remote or allosteric site
(Figure 1.16). Controlling enzyme activity permits the fine tuning necessary
to balance the rate of synthesis of end products of the pathway with the
production of subsequent larger macromolecules, and prevents the organism
from expending unnecessary resources, such as nitrogen and energy, on end
products that are not required.
In 1965, Monod, Wyman and Changeux summarised the properties of a
number of allosteric enzymes resulting in their plausible model on the nature
of allosteric transition (known as the MWC model, Figure 1.17).85 Since then,
the description of numerous enzymes had led to the concept that allostery is
a common theme in enzyme regulation.
(a)
(b)
Figure 1.16: Cartoon representation of a monomeric, allosterically-regulated en-
zyme. The binding of an allosteric effector alters the active site or substrate binding
site in either an (a) unfavourable or (b) favourable way, causing either a decreased
affinity for substrate binding and therefore decreased catalytic activity or increase
in catalytic efficiency resulting from increased substrate affinity, respectively.
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Figure 1.17: Cartoon representation of the Monod-Wyman-Changeux (MWC)
model of allosteric transitions. A symmetric multimeric protein can exist in either
of two conformational states, relaxed (R) or tense (T), that differ in their binding
affinities for the ligand. Each subunit has distinct binding sites for the allosteric
effector and the substrate (active site).
Discovery of Allosteric Regulation
Allosteric regulation was recognised well before the process was understood.
The two earliest examples were the observation of a sigmoidal binding curve
of haemoglobin to oxygen86 (known as the Bohr effect), and the recognition
of the activation of glycogen phosphorylase by AMP.87 Although equations
were derived to describe the processes,88 it was not until the 1950s, with
the discovery that Trp inhibited the synthesis of Trp synthetase in E. coli,89
that the hypothesis of feedback regulation by pathway end products was
formulated. This theory was demonstrated by Umbarger who showed that in
many pathways an early enzyme is constructed to be strongly and specific-
ally inhibited by the metabolic end product of the pathway.90 The sites of
regulatory molecule binding were renamed allosteric (Greek: allos “other”,
steric “site”) to denote that the inhibitory effect occurs at a site distinct
from the active site of the enzyme, and that the inhibitor is not simply a
steric analogue of the substrate.91–93 It has been suggested that allosteric sites
may be more useful drug targets than active sites despite the difficulty in
predicting the chemical nature of effectors and consequent slow discovery.91
In the past, allostery was typically referred to as “cooperativity”, a
term used to describe allosteric regulation in proteins composed of multiple
subunits, where binding of a ligand to one subunit increases the affinity
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of the other subunits for the same ligand (known as homotropic allostery).
Examples were limited to multimeric proteins such as the classic haemoglobin
and aspartate transcarbamoylase models.85,94 Most allosteric effects can be
explained by the concerted MWC model (Figure 1.17) or by the sequential
Koshland-Nemethy-Filmer (KNF) model (Figure 1.18).
The central postulate of the MWC model is the existence of two distinct
symmetric states of a protein composed of multiple subunits, R (relaxed)
and T (tense). All subunits must exist in the same state. An equilibrium
is assumed to exist between these two states of a protein and the position
of this equilibrium is affected by ligand (or substrate) binding. Although
the ligand can bind either protein state, the R form has a higher binding
affinity for the ligand resulting in a shift of the equilibrium position towards
the R form, in turn providing more high affinity binding sites for the ligand.
This model explains the characteristic sigmoidal binding curve observed for
proteins which display cooperative transitions between two distinct states, as
a small ligand concentration will lead to a vast increase in the proportion of
molecules in the R state and therefore will lead to a high association of ligand
to the protein. However, the MWC model does not account for negative
cooperativity.
The KNF model or sequential model for allosteric transitions (Figure
1.18) proposes that a conformational change in one subunit of a protein
does not induce a similar change in the other subunits therefore all enzyme
subunits do not necessitate the same conformation. Binding of a ligand
induces a conformational change in the subunit to which it binds. There
is no requirement for conservation of symmetry, the subunits can assume
different conformations. If the interactions between the subunits are tightly
coupled, binding of the ligand could cause the adjacent subunit(s) to adopt a
conformation having a greater or lesser affinity for the ligand.
Today, allostery is considered to be a far more general property of
proteins and it is also recognised in monomeric proteins (Figure 1.16).96–98
Catalysis and allostery of proteins arise, in principle, from an intrinsic
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Figure 1.18: Schematic representation of the conformational states of a tetrameric
protein according to the Koshland-Nemethy-Filmer (KNF) model for allosteric
transitions. Illustration adapted from Garrett and Grisham.95
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property of proteins, their conformational flexibility. This property allows the
protein to interconvert between populations of conformers. The binding of a
ligand can perturb this equilibrium and change the population distribution
and/or the conversion rates between conformers. This results in modified
properties of the active site or of binding-site geometries, and thereby rates
of catalysis or binding affinities.99,100
The concept of large conformational changes being associated with
remote ligand binding has been debated, as significant backbone deformations
are not always a defining characteristic of allosteric effects. Changes in
protein dynamics may also contribute to allostery.101,102 Stably-folded proteins
undergo fluctuations, especially of amino acid side chains, and it has been
suggested that this imparts conformational entropy which could be important
for regulation.101
Allosteric regulation is an efficient means for proteins to sense the
changing conditions of the cell and respond to maintain cellular homeostasis.
It provides a mechanism to directly sense the levels of small molecules, and
can be very rapid (on the same order as the rate of diffusion) and readily
reversible. Unlike covalent protein modification, no cellular energy is expended
in allosteric signalling.
1.3.4 Regulation of DAH7PS
Typical of many biosynthetic pathways, the overall flux through the shikimate
pathway is controlled via allosteric regulation of DAH7PS activity by pathway
intermediates or end products. 13C-NMR studies using whole cells of E. coli
have shown that feedback inhibition of DAH7PS is the main method for
controlling carbon flux through the shikimate pathway and cellular levels of
aromatic compounds in microorganisms.20 Different species appear to have
adopted a variety of control patterns for DAH7PS activity and these divergent
mechanisms of control are associated with the different types of DAH7PS
(Figure 1.19). Some organisms have two or more isozymes, which are feedback
inhibited by end products or intermediates of the pathway, or a combination
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(a) (b)
(c) (d)
Figure 1.19: Different strategies for the feedback regulation of the DAH7PS
enzymes (a) PfuDAH7PS, (b) TmaDAH7PS, (c) EcoDAH7PS and (d)MtuDAH7PS.
Barrel regions are coloured blue, and (putative) regulatory regions are coloured
red (N-terminal) and internal extensions are coloured yellow.
28
of end products. DAH7PSs from some organisms are not regulated.40,48,103
Type Iα DAH7PSs
One approach to allostery adopted by the Iα DAH7PSs is mediated through
the expression of multiple isozymes. Scattered throughout the E. coli genome
are genes encoding for three isozymes of DAH7PS, designated DAH7PS(Tyr),
DAH7PS(Phe) and DAH7PS(Trp), and defined by the amino acid to which
they show sensitivity. These proteins are encoded by the genes aroF, aroG and
aroH, respectively.5 Each isozyme is feedback inhibited by their associated
aromatic amino acid.
The majority of the DAH7PS activity in E. coli arises from the Eco-
DAH7PS(Phe) isozyme (eighty percent), with twenty percent of the total
DAH7PS activity through EcoDAH7PS(Tyr), and the EcoDAH7PS(Trp)
enzyme contributing less than one percent.81 Similarly, Neurospora crassa
and Salmonella typhimurium express three DAH7PS isozymes. However, the
genome of S. cerevisiae encodes for only two isozymes, which have been shown
to be sensitive to only Phe or Tyr.33
Crystal structures of both EcoDAH7PS(Phe) and SceDAH7PS(Tyr)
show the regulatory amino acids, Phe and Tyr, bind to these enzymes in very
similar positions. The N-terminal extension and an internal extension between
helix α5 and β6 together create a single binding site on the N-terminal end of
the (β/α)8 barrel to which the inhibitor molecule binds, resulting in inhibition
of the enzyme (Figure 1.20).32–34,104
When the ligand-bound structures of either EcoDAH7PS(Phe) or Sce-
DAH7PS(Tyr) are overlaid on their unliganded forms, only very minor dif-
ferences are observed in the structures (Figure 1.20) with only a slight per-
turbation of the binding loops responsible for substrate binding. It has been
proposed for EcoDAH7PS(Phe) that the inhibitory signal is propagated from
the allosteric site and affects the active site in two ways. A cascade of con-
formational changes are thought to result in perturbation to the interaction of
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(a) (b)
Figure 1.20: Monomer subunits of type Iα showing limited conformational change
on ligand binding. (a) Overlay of the monomer of EcoDAH7PS(Phe) with (PDB
code 1KFL) and without (PDB code 1QR7) Phe (cyan sticks) bound. (b) Overlay
of Tyr bound and unbound SceDAH7PS(Tyr) (PDB codes 1OF6 and 1OFB,
respectively). N-terminal extensions are coloured red and internal extensions are
coloured yellow. Bound structures are coloured in the corresponding, but lighter
shade to the unbound structures. The active-site metal ion is shown as a magenta
sphere.
DAH7PS with both substrates. These changes result in the loss of E4P bind-
ing and PEP binding in a non-catalytically competent flipped orientation.104
Sequence analysis of type Iα DAH7PSs reveals a highly conserved serine
(Ser) residue in all Phe-regulated enzymes (position 219 SceDAH7PS(Phe)
numbering), and a highly conserved glycine residue in all Tyr-sensitive en-
zymes (position 226 SceDAH7PS(Tyr) numbering).33 Analysis of the crystal
structure of SceDAH7PS(Tyr) shows G226 is located at the bottom of the
putative effector binding cavity. This cavity is significantly reduced in Sce-
DAH7PS(Phe), caused by the side chain of the highly conserved Ser residue
of SceDAH7PS(Phe) protruding out into the cavity, instead of the simple
hydrogen side chain of glycine (Gly) found in SceDAH7PS(Tyr). A single
amino acid substitution in this position from Gly to Ser (Figure 1.21) was
shown to completely interchange sensitivity of these S. cerevisiae enzymes
from Phe to Tyr, without effecting the kinetic properties of the enzyme.33
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Figure 1.21: Overlay of SceDAH7PS(Tyr) G226S mutant in complex with Phe
(PDB code 1GO0) (unpublished) and wild-type SceDAH7PS(Tyr) in complex with
Tyr (PDB code 1OF6). Both the Tyr molecule and Gly226 of SceDAH7PS(Tyr)
are coloured yellow. The Phe molecule and residue Ser226 of the G226S structure
are coloured cyan. Note: the sidechain of S226 is only modelled to the Cβ atom in
all subunits of the G226S mutant structure.
Type Iβ DAH7PSs
Three members of the type Iβ DAH7PS subfamily have been structurally
and functionally characterised.38–40,48,64 Of these, two, PfuDAH7PS48 and
ApeDAH7PS,40 are constructed of only a simple core catalytic barrel (Figure
1.22a and 1.22b) and no allosteric effectors have been identified for these
proteins. The other, TmaDAH7PS, has a FL domain attached to the N
terminus of the barrel39 (Figure 1.22c) and is inhibited by two of the three
aromatic amino acids, namely Tyr and Phe.64
A single DAH7PS is found for B. subtilis with a chorismate mutase (CM)
domain fused to the N terminus.105 Similarly, P. gingivalis also has a CM
fusion, but this extension is located at the C-terminal end of the protein.105
In both of these cases CM is the regulatory domain, which facilitates feedback
regulation by an intermediate of the pathway, chorismate, rather than pathway
end products.23,105
Truncation of the terminal CM domains from BsuDAH7PS and P.
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(a) (b)
(c)
Figure 1.22: Structural comparison of type Iβ DAH7PS enzymes. (a) PfuDAH7PS,
(b) ApeDAH7PS and (c) TmaDAH7PS. The core barrel is coloured blue with the
N-terminal extension coloured red.
gingivalis DAH7PS (PgiDAH7PS) results in the loss of feedback inhibition
by chorismate, strengthening the observation that feedback regulation is
achieved through the extra domain elements. This suggests that these enzymes
recruited the CM domain for the purpose of feedback regulation rather than
to create bifunctional enzymes.23
Sequence analysis suggests that the Iβ subfamily also contains examples
of DAH7PS isozymes, including those from Thermus thermophilus, where one
appears to have a similar extension to TmaDAH7PS, and the other resembles
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a CM-fused DAH7PS.
Although the N- or C-terminal extensions have been implicated in the
feedback inhibition of the type Iβ DAH7PS, no mechanism has been proposed
for the propagation of the regulatory signal from the allosteric site to the
active site of the enzyme.39 Furthermore, as no crystal structure of a ligand-
bound type Iβ DAH7PS had been solved at the commencement of this thesis,
the binding site for the ligands had not yet been determined.
Type II DAH7PSs
M. tuberculosis expresses a single type II DAH7PS enzyme and it has been
recently discovered that MtuDAH7PS displays a more complex method of
regulation than most other DAH7PSs. MtuDAH7PS is only weakly regulated
by single aromatic amino acids, but displays greatest inhibition by a combin-
ation of two amino acids binding simultaneously to two binding sites formed
by two distinct additions to the catalytic barrel.66 This unusual but highly
specialised mechanism of regulation, synergistic inhibition, allows the control
of enzyme activity in response to the production of multiple pathway end
products.
It is suggested that inhibition of MtuDAH7PS catalysis occurs physically
by perturbation of the loops associated with E4P binding.66 Comparison of
ligand-bound and unliganded crystal structures of MtuDAH7PS show only
minor conformational differences (Figure 1.23) and the loop containing the
conserved KPRS motif, responsible for E4P binding, is slightly displaced but
significantly more disordered on ligand binding, disfavouring binding of E4P.
These results suggest that contributions from altered dynamics of the enzyme
may be responsible for allosteric regulation.106
MtuDAH7PS is not the only example of a synergistically regulated
type II DAH7PS. Similarily, DAH7PS from Corynebacterium glutamicum,
is reported to be strongly inhibited by a combination of Tyr and Phe, and
shows further inhibition when Trp is added.107
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Figure 1.23: Superposition of an non-liganded (PDB code 3B70) and ligand-
bound (PDB code 3KGF) monomer of MtuDAH7PS. The non-liganded structure is
coloured purple with the N-terminal extension coloured red and the internal barrel
extension coloured yellow. The ligand-bound structure is shown in lighter shades
of the same colours. The ligands, Phe and Trp, are shown as sticks and coloured
cyan, and the active-site metal ion is shown as a magenta sphere.
As well as catalysing the first reaction on the pathway, MtuDAH7PS is
also involved in the regulation of the branch point that occurs at chorismate.
MtuDAH7PS forms a complex with M. tuberculosis CM.108 This interaction
results in significant activation of CM and the end products of this branch
point, Phe and Tyr, inhibit this enhanced activity. It is unknown how
CM activity is altered but the observation of stimulation of CM activity by
association with DAH7PS is consistent with observations made for the same
enzymes from A. methanolica.43,109
Although sequence analysis suggests some of the type II DAH7PS
enzymes characterised to date appear to have the extensions required to
facilitate regulation, allosteric effectors have not been identified for all type
II enzymes.47 Those with known inhibitors are subject to feedback regulation
by either intermediates42 or end products of the shikimate pathway.103,110
Sequence alignments have also identified a subgroup of type II enzymes with
a significant deletion (approximately 45 residues). It has been suggested
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this deletion is a characteristic of type II DAH7PS enzymes involved in
secondary metabolism47 and that this region dictates allosteric specificity
towards chorismate and Trp.42
1.4 Objectives of Thesis
The overall aim of this research is to unravel the evolutionary events that
have led to complex and diverse contemporary mechanisms of regulation
of the important biosynthetic enzyme DAH7PS. The prediction that the
diverse regulation strategies for controlling DAH7PS activity have evolved
from domain recruitment, by adding regulatory units to the catalytic barrel
(Figure 1.24), will be investigated. To directly test this hypothesis, chimeric
proteins with combinations of catalytic and regulatory domains from the
type Iβ DAH7PSs will be constructed and characterised to ascertain whether
regulation can indeed be introduced and eliminated as proposed. The aim
is to investigate whether the putative FL regulatory domain of the type Iβ
DAH7PS enzymes does control allostery and to uncover how this regulatory
domain (if in fact it is) modulates enzyme activity. This information will be
used to better understand more general regulation strategies of DAH7PS.
Specifically, the following studies are described in this thesis:
• the truncation of TmaDAH7PS by removing the putative regulatory
domain to ascertain whether the extra domain element is essential for
feedback regulation, catalytic activity and stability of the enzyme;
• an investigation of how the regulatory domain of TmaDAH7PS facilitates
and communicates feedback inhibition to the active site;
• a study of the interactions between the putative regulatory domain
and TIM-barrel domains, which are essential to transmit the feedback
regulation signal to the active site;
• mutagenesis experiments designed to uncover the interactions between
the regulatory molecule and ligand that govern the specificity and
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Figure 1.24: Proposal for the evolution of complex regulatory systems in
DAH7PSs
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effectiveness of the inhibitory molecule;
• investigations into whether the single amino acid exchange responsible
for switching sensitivity between Phe and Tyr in the type Iα DAH7PS
can be applied to type Iβ DAH7PS enzymes;
• the construction of a chimeric protein composed of a putative regulat-
ory domain from a regulated DAH7PS with the TIM-barrel from an
unregulated DAH7PS, to uncover whether allosteric regulation can be
introduced by simple fusion of these two domains.
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Chapter 2
Expression and Biochemical
Characterisation of Type Iβ
Thermotoga maritima
DAH7PS
2.1 Introduction
Hyperthermophiles are a unique group of microorganisms that have a re-
markable ability to grow at a temperature of 70℃ or above and have been
isolated from geothermally-heated environments including deep-sea hydro-
thermal vents.111 The hyperthermophiles are highly divergent microorganisms
phylogentically, and although most of the hyperthermophilic genera are classi-
fied as Archaea, two groups, Thermotogales and Aquificales, belong under the
domain Bacteria.111,112 T. maritima, from the order Thermotogales, was ori-
ginally isolated from geothermally-heated marine sediment at Vulcano, Italy
and grows at temperatures between 55℃ and 90℃ with an optimal growing
temperature of 80℃.113 Along with Aquifex species, T. maritima is thought
to be one of the most thermophilic Eubacteria currently known. Evolutionary
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studies have placed this bacterium on one of the slowest evolving branches of
the domain Bacteria114,115 and it has therefore been suggested that study of
this bacterium may provide insight into the divergence of the classes of the
DAH7PS enzyme.64 The genome of T. maritima encodes for a single DAH7PS
that belongs to the type Iβ family. Although the characterisation of this
enzyme had already been reported at the time of this study,64 it was thought
that additional characterisation was important to serve as a comparison for
further studies. The expression, purification, biochemical characterisation
and inhibition of TmaDAH7PS is presented in this chapter.
2.2 Cloning and Expression
Prior to the start of these studies, Dr.Mark Patchett had used standard
methodologies to amplify the TmaDAH7PS gene (locus tag TM0343) from
purified T. maritima MSB8 (DSM 3109) genomic DNA, and ligated it into the
pT7-7 vector.116 Plasmid DNA was isolated from ampicillin (Amp)-resistant
colonies of transformed E. coli XL1-Blue cells, sequenced, and transformed
into E. coli BL21(DE3)-Rosetta cells (Novagen) (for further details refer to
Chapter 8).
The expression of TmaDAH7PS produced protein of the predicted
subunit molecular weight and the TmaDAH7PS insert in the expression
plasmid was sequenced and found to be identical to the desired sequence.
The cells were grown and protein expression induced by the addition of
isopropyl-1-thiol-β-d-galactopyranoside (IPTG). Cells were harvested four
hours after induction, lysed by sonication on ice and cell debris removed by
centrifugation. The soluble fraction was found to exhibit DAH7PS activity.
Attempts to replicate the reported method for expression and purifica-
tion of TmaDAH7PS were made but resulted in very small yields of protein.64
Numerous strategies were employed to improve the expression level and yield
of soluble protein. Methods trialled included the use of auto-induction media
and varying lysis conditions. Detergent-based methods and different temper-
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atures and duration of sonication were tested, none of which appeared to
make any difference to the overall yield of soluble protein within the crude
lysate.
The gene encoding TmaDAH7PS was inserted into the alternative ex-
pression vector, pET151-D-TOPO® (Invitrogen). pET151D® allows expression
of recombinant protein containing a N-terminal 6×His fusion tag for ease of
detection and purification. The N-terminal tag also includes a Tobacco Etch
Virus (TEV) protease cleavage site to enable removal of the tag using TEV
after protein purification. Numerous attempts at purification of this construct
were made, however the majority of protein was lost during the immobilised
metal affinity chromatography (IMAC) step, so the pT7-7 construct was used
for non-tagged expression.
Occasionally, sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE) of the protein expressed from the pT7-7 vector revealed the
presence of a slightly smaller molecular weight protein under the band for
TmaDAH7PS. This smaller protein band was attributed to the cleaving of a
small number of residues from a terminal end of TmaDAH7PS by native E.
coli proteases present in the crude lysate. The addition of protease inhibitors,
prior to lysis, appeared to decrease the appearance of this double banding.
Although the yield of soluble protein was not ideal, expression from the pT7-7
construct was used for purification.
2.3 Purification
A three step purification protocol was developed based on the heat stability
and calculated isoelectric point (pI) (6.3) of TmaDAH7PS. Fractions were
selected and pooled on the basis of purity rather than for total enzyme recovery.
Whole cells were lysed on ice using a cell disruptor, and the resulting lysate
divided into small aliquots, heat treated, left to cool to room temperature,
and clarified by centrifugation. Following heat treatment, SDS-PAGE analysis
showed a number of contaminants were still present in the sample and hence,
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Figure 2.1: SDS-PAGE analysis of TmaDAH7PS purification by SEC. Lane M:
molecular weight marker; other lanes correspond to the fraction loaded from the
SEC column.
further purification steps were required.
Hydrophobic-interaction chromatography (HIC) is a chromatography
technique that separates biomolecules according to their hydrophobic proper-
ties. Although most hydrophobic amino acids are buried in the interior of
globular proteins, some of them are exposed on the protein surface. Proteins
are separated due to the strength of the interaction between these exposed
residues with hydrophobic groups attached to an uncharged matrix. Proteins
bind at high ionic strength and are eluted from the column as the ionic
strength is lowered. This technique was employed to further purify Tma-
DAH7PS from contaminating proteins. Ammonium sulfate was added to
the supernatant to a final concentration of 1M, before the supernatant was
applied to a hydrophobic interaction column equilibrated in a high salt buffer
(1M (NH4)2SO4). When a gradient from 1M to 0M ammonium sulfate was
applied, the protein was found to elute across the entire gradient. Subsequent
purifications therefore used a stepwise elution with an immediate change from
high salt to low salt. Fractions corresponding to the 280 nm absorbance peak
observed at zero percent salt were pooled and concentrated.
Size-exclusion chromatography (SEC) was employed as a final polishing
step for all purifications. Interestingly, the protein peak eluted from the SEC
column was often found to be contaminated by a smaller molecular weight
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Figure 2.2: SDS-PAGE analysis of the purification of TmaDAH7PS. Lane 1:
supernatant after heat treatment; lane 2: pooled HIC fractions; lane 3: pooled
SEC fractions; lane M: molecular weight marker.
protein (Figure 2.1). Maximum separation of TmaDAH7PS and the smaller
contaminating protein was achieved by slow elution from the column (Figure
2.2).
Due to small yields of protein (<2mg L−1 of culture volume), alternative
purification methods were trialled in an attempt to improve protein yield.
Purification consisting of heat treatment, followed by two passes down an
anion-exchange chromatography (AEC) was trialled and compared to the
above method. Unfortunately this protocol resulted in a substantial loss of
protein during the AEC and co-elution with other proteins resulted in a more
contaminated sample.
In order to obtain a useful amount of purified protein (10mg), 4 L
growth cultures were necessary.
2.4 Confirmation of Molecular Weight
The molecular mass of TmaDAH7PS was 37382.6 ± 0.4Da as determined by
electrospray ionisation mass spectrometry. This is in close agreement with
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the 37378.1Da molecular weight calculated from the 338 amino acid open
reading frame (ORF) encoding for TmaDAH7PS.
2.5 Kinetic Parameters
The steady-state kinetic parameters for freshly purified TmaDAH7PS were
measured by following the disappearance of PEP absorbance at 232 nm. Al-
though the optimal temperature for enzymatic activity of TmaDAH7PS has
been reported to be 90℃,64 the marked decrease in E4P stability over time
at elevated temperatures restricts the temperature at which a continuous
spectrophotometric assay can be performed. To minimise this effect, Tma-
DAH7PS was assayed in the same manner described for PfuDAH7PS,38 by
continuous spectrophotometric assay performed at 60℃ and initiated with
E4P. An advantage of continuous assays over discontinuous assays is increased
accuracy, which results from the measurement of a larger number of data
points.38 This assay system differs from that used in the characterisation of
other type Iβ DAH7PS enzymes. The kinetic properties of PgiDAH7PS,23
BsuDAH7PS,23 ApeDAH7PS40 and TmaDAH7PS64 were explored by a discon-
tinuous colourimetric or aminoff periodate-thiobarbituric acid assay system,
or a combination of both continuous and discontinuous methods. All assays
were initiated by the addition of E4P rather than enzyme.
Initial velocity rates of TmaDAH7PS catalytic activity were calculated
Table 2.1: Kinetic parameters for type Iβ DAH7PS enzymes
Enzyme KPEPm (µM) KE4Pm (µM) kcat (s−1) Temp. (℃) Reference
PfuDAH7PS 120 ± 20 28± 4 1.5± 0.1 60 Schofield38
TmaDAH7PS 12 ± 2 138± 11 5.0± 0.3 60 Wu64
PgiDAH7PS 2724 ± 256 3638± 375 1.6± 0.1 37 Wu105
BsuDAH7PS 142 ± 9 1400± 60 4.2± 0.2 37 Wu105
ApeDAH7PS 890 ± 30 280± 20 1.0± 0.2 60 Zhou40
TmaDAH7PS 4.9± 0.4 13± 1 11.7± 0.2 60 This study
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Table 2.2: Optimal growth and assay temperatures for type Iβ DAH7PS enzymes
Organism/ Assay Optimal Growth
DAH7PS source Temperature (℃) Temperature (℃)
P. furiosus 60 100117
T. maritima 60 80113
P. gingivalis 37 37118
B. subtilis 37 28–30119
A. pernix 60 90–95120
with the concentration of one substrate fixed while the other substrate concen-
tration was varied. The apparent Km values for PEP and E4P were found to
be 4.9 ± 0.4µM and 13 ± 1 µM respectively, and the kcat value was calculated
as 11.7 ± 0.2 s−1.
It is difficult to accurately compare kinetic parameters between the
type Iβ DAH7PSs as there is a large variation in assay conditions and the
temperatures used are not always those that give maximal rates (Table 2.2).
However, the Km values determined for TmaDAH7PS are broadly in line with
those previously reported for TmaDAH7PS (Table 2.1)64 with the notable
exception of the order of magnitude lower KE4Pm value.
2.6 Metal Activation
Consistent with other DAH7PS enzymes characterised to date, TmaDAH7PS
requires a divalent metal ion for catalysis. Buffer and substrate solutions used
in metal reactivation studies were treated with Chelex® (an ion-exchange
resin that removes polyvalent metal ions) prior to use to avoid contamination
from other metal sources. Enzyme activity was not detectable after the
addition of 10µM EDTA to the buffer. These results differ from other
studies in which treatment of X. campestris, S. aurantiaca and Streptomyces
caespitosus DAH7PSs with EDTA resulted in only partial deactivation of
enzyme activity.42,110,121
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Figure 2.3: Extent of reactivation of TmaDAH7PS by various divalent metal ions.
Activity of the apo-enzyme could be restored by addition of Zn2+, Cd2+
and Co2+, with Mn2+ resulting in the fastest reaction rates (Figure 2.3).
These results are consistent with previous reports for TmaDAH7PS and other
type Iβ DAH7PS enzymes.23,38,40,64
2.7 Feedback Inhibition
As previously reported, the catalytic activity of TmaDAH7PS is sensitive to
the presence of aromatic amino acids.64 The degree of sensitivity of Tma-
DAH7PS towards Phe, Tyr and Trp was investigated using standard assay
conditions. The three amino acids were tested at a number of concentrations
and it was found that Tyr caused a substantial decrease in catalytic activity,
whereas Phe was less inhibitory (Figure 2.4). No significant reduction in
activity was observed in the presence of Trp. In the presence of increasing
concentrations of Tyr, enzyme activity decreased to a constant eighteen
percent residual activity.
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Figure 2.4: Response of wild-type TmaDAH7PS activity to increasing concentra-
tions of Tyr (), Phe (◦) and Trp (N). The data points were measured in triplicate
with the error bars indicating the standard deviation.
2.8 Kinetic Parameters in the Presence of
Tyr
Determination of the kinetic parameters of TmaDAH7PS in the presence
of Tyr (150µM) indicated that the wild-type protein has a reduced affinity
for both substrates (KPEPm of 21 ± 1 µM, KE4Pm of 118 ± 10 µM) as well as
significantly lower kcat of 2.79 ± 0.08 s−1 when compared with the parameters
determined for this enzyme in the absence of this inhibitor (Table 2.1).
2.9 Differential Scanning Calorimetry
To investigate the heat stability of TmaDAH7PS and to probe any changes
to thermal stability in the presence of Tyr, differential scanning calorimetry
(DSC) experiments were carried out to determine the protein denaturation
temperature (Tm). The result confirmed the high thermal stability of Tma-
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(a) (b)
Figure 2.5: Differential scanning calorimetry of wild-type TmaDAH7PS in the
(a) absence and (b) presence of Tyr showing the subtracted raw data (—), first
Tm (---), second Tm (---) and the overall fit of the two state model (---).
DAH7PS, which denatured in two transitions, with the first Tm occurring at
96.8℃ and the second at 101℃. Addition of Tyr to the enzyme resulted in
increased heat stability, with two thermal transitions observed at 102℃ and
105℃ (Figure 2.5).
2.10 Discussion
TmaDAH7PS was successfully purified and has been shown to be a thermally
stable, metal-dependent enzyme that is inactivated by Tyr. Although a
different purification method was developed, metal dependency and inhibition
results are in agreement with what has been previously reported.64 Mn2+ was
the most activating divalent metal ion for TmaDAH7PS, although the order
of metal reactivation series differs. Tyr and Phe inhibit the catalytic activity
of the enzyme with Tyr being the more potent inhibitor.
Although it is suggested the N-terminal domain of TmaDAH7PS is
required for the allosteric regulation of the enzyme,39 further investigation is
required to affirm this hypothesis. Will removal of this domain result in a
catalytically active, unregulated enzyme?
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Chapter 3
Expression and Biochemical
Characterisation of Truncated
Thermotoga maritima
DAH7PS
3.1 Introduction
Previous studies have suggested that the extra domain elements found fused
to the catalytic barrel of the DAH7PSs were acquired for the purpose of
feedback regulation.32–34,39,104,122 It is considered likely that contemporary
DAH7PSs evolved from a primitive, unregulated and undecorated type Iβ-like
enzyme and, while some members have remained unregulated, others have
acquired an extra domain for regulation by feedback inhibition. The type Iα
and type II subfamilies have evolved in a more complex manner, acquiring
insertions or extensions within the (β/α)8 barrel itself, in addition to those
found at the N terminus, to function as regulatory elements.105
The type Iβ subfamily has been found to be the most widely distributed
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type of DAH7PS in nature, and it has therefore been proposed that this
group of contemporary enzymes are the most closely related to the ancestral
DAH7PS.42 This subfamily is therefore an ideal system for examining the
acquisition of feedback regulation in these enzymes. Type Iβ DAH7PSs consist
simply of the (β/α)8 barrel alone, such as the unregulated PfuDAH7PS48 and
ApeDAH7PS40 or have an N-terminal or C-terminal extension to the catalytic
barrel. The Iβ enzymes also include the DAH7PS-CM fusion proteins.105
TmaDAH7PS is a member of the type Iβ subfamily. This enzyme has
been shown to have a FL domain at its N terminus that has been implicated
in the sensitivity of this enzyme towards the aromatic amino acids.39,64
The expression using various vectors, in vivo solubilisation, purification and
biochemical characterisation of TmaDAH7PS with its N-terminal FL-domain
removed is described in this chapter.
3.2 Choice of Truncation Site
To examine the role of the putative regulatory extension of TmaDAH7PS, a
truncated mutant lacking this N-terminal domain was developed (truncTma-
DAH7PS). The basis of the truncation was determined from a structural
comparison with the unregulated PfuDAH7PS enzyme (Figures 3.1 and 3.2).
To correspond to the start of the PfuDAH7PS protein truncTmaDAH7PS
started at Leu71.
3.3 truncTmaDAH7PS – pET151D-TOPO®
3.3.1 Cloning and Expression
DNA corresponding to the ORF of truncTmaDAH7PS was amplified from the
plasmid containing the gene encoding for wild-type TmaDAH7PS, purified,
concentrated and ligated into the pET151/D-TOPO® vector using TOPO®
49
Figure 3.1: Overlay of the monomer units of the regulated TmaDAH7PS (PDB
code 1RZM) coloured blue, with the unregulated, naturally truncated PfuDAH7PS
(PDB code 1ZCO), coloured yellow.
cloning. This vector enables the expression of a clone with a N-terminal TEV
protease cleaveable His-tag, which after cleavage leaves the desired protein with
six non-native amino acids at the N terminus. The truncTmaDAH7PS ORF
containing plasmid was transformed into E. coli One Shot® BL21 Star™(DE3)
cells and DNA sequencing of the plasmid confirmed the identity of the
truncTmaDAH7PS ORF. Cells were grown, protein expression induced, cells
lysed and the resulting crude lysate examined. SDS-PAGE analysis showed an
over-expressed protein of the predicted molecular weight for truncTmaDAH7PS
(approximately 30 kDa). Following cell lysis and centrifugation, equal amounts
of the protein of interest were evident in the supernatant and cell debris. This
distribution of protein was attributed to incomplete lysis of a small volume
of resuspended cells. Preliminary activity assays confirmed the presence of
DAH7PS catalytic activity.
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Figure 3.2: ClustalW sequence alignment of type Iβ DAH7PS sequences.
TmaDAH7PS has a N-terminal ferredoxin-like (FL) putative regulatory domain.
Both PfuDAH7PS and ApeDAH7PS are naturally occurring truncated DAH7PS
enzymes while truncTmaDAH7PS has been engineered to resemble an undecorated
DAH7PS enzyme. The Tobacco Etch Virus (TEV) protease recognition site of the
truncTmaDAH7PS pET151/D-TOPO® construct is highlighted in yellow.
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3.3.2 Purification
As truncTmaDAH7PS was expected to have similar physical properties to
PfuDAH7PS, a similar purification strategy was adopted.38 Heat treatment
was investigated as a potential one-step purification method. Enzymes tolerant
of high temperatures can be easily purified by simple heat treatment after
expression in a mesophile such as E. coli, as most of the host’s own proteins
denature and precipitate. This results in rapid and partial purification of
thermostable enzymes, free from contaminating activities.123 Heat treatment
trials were conducted at 60℃, 70℃ and 80℃, for 30min to 60min. All
conditions significantly purified the protein with no distinguishable difference
in protein purity between temperatures or period of time. For subsequent
purifications the supernatant post-lysis was heat treated at 60℃ for 30min
and the samples were left to cool to room temperature to ensure maximum
precipitation of contaminating proteins.
IMAC, using a chelating-Sepharose column charged with either Ni2+ or
Co2+, was employed as a second purification step to take advantage of the
polyvalent His-tag introduced to the N terminus of the protein. Unfortunately,
only small amounts of protein were recovered from these columns and SDS-
PAGE analysis of the flow through, urea suspensions, and regeneration of
columns to assess affinity of the protein for the column, were unable to locate
the majority of the protein.
The ability of TEV protease to cleave the polyvalent His-tag introduced
to the N terminus of truncTmaDAH7PS was then assessed on protein that had
been heat treated (Figure 3.3). Different concentrations of TEV, temperature
and duration of incubation were trialled and all suggested truncTmaDAH7PS
undergoes only partial cleavage of the His-tag by TEV. Due to the inability
to utilise the His-tag in the purification of truncTmaDAH7PS, expression of
the protein in this vector was abandoned.
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Figure 3.3: truncTmaDAH7PS pET151/D-TOPO® SDS-PAGE analysis showing
only partial TEV protease cleavage. Lane M: molecular weight marker; lane 1:
resuspended cell pellet; lane 2: crude lysate after sonication; lane 3: resuspended
cell debris after sonication; lane 4: supernatant post heat treatment; lane 5:
resuspended debris after heat treatment; lane 8: supernatant after TEV protease
treatment left overnight at 4℃.
3.4 truncTmaDAH7PS – pDEST15 and
pDEST566
3.4.1 Cloning and Expression
Given the unsuccessful attempts to purify truncTmaDAH7PS expressed in
the pET151/D-TOPO® vector, expression in an alternative vector was in-
vestigated. The gene encoding for truncTmaDAH7PS was amplified using
the pET151/D-TOPO® vector as a template and standard polymerase chain
reaction (PCR) methodologies, and ligated into a Gateway®-adapted entry
vector, pDONR™221, using Gateway® technology. This vector permits recom-
bination cloning into multiple destination vectors allowing optimal expression
of the gene of interest. Entry clones were transformed into One Shot® TOP10
cells. Colony PCR was used to check for colonies with gene inserts of the
approximate size expected for truncTmaDAH7PS and directionality of the
insert.
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Expression clones were then generated in two vectors encoding different
N-terminal fusion tags, pDEST15 (glutathione S-transferase (GST)) and
pDEST566 (maltose binding protein (MBP)), using Gateway® technology. A
major advantage of GST and MBP tags is that they allow affinity purification
of the fusion protein with mild elution conditions, and they are known to
enhance the solubility of their fusion partners.124 Following recombination,
the vectors were transformed into E. coli One Shot® BL21 Star™ (DE3)
and Rosetta™ 2 (DE3) cells. Rosetta™ 2 (DE3) host cells were used to try
to improve the expression level of truncTmaDAH7PS. These cells are BL21
derivatives designed to enhance the expression of proteins that contain codons
rarely used in E. coli. As the nucleotide sequence of truncTmaDAH7PS has
rare codon usage, Rosetta™ 2 (DE3) cells might be expected to improve
protein expression.
Trials were conducted to compare the lysis methods of sonication and
a more gentle detergent-based lysis method in both the BL21 Star™ (DE3)
and Rosetta™ 2 (DE3) cell lines. Following cell lysis and centrifugation,
SDS-PAGE analysis showed the protein of interest was only evident in the cell
debris of cells expressing the GST-tagged protein. However, the supernatant
resulting from sonication of the BL21 Star™ (DE3) cells expressing the MBP-
tagged protein contained some soluble protein (Figure 3.4), therefore this
construct was pursued.
3.4.2 Purification
BL21 Star™ (DE3) transformants harbouring the pDEST566-MBP-truncTma-
DAH7PS plasmid were grown and protein expression was induced by addition
of IPTG. Cell pellets were resuspended, sonicated and clarified by centrifuga-
tion.
The supernatant liquid was applied to a MBPTrap™ HP column (GE
Healthcare) and truncTmaDAH7PS eluted with maltose. Fractions containing
truncTmaDAH7PS were concentrated and desalted. The MBP-tag was cleaved
from truncTmaDAH7PS using TEV protease and the protein was heat treated,
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Figure 3.4: SDS-PAGE analysis of the expression of truncTmaDAH7PS from
pDEST566 and pDEST15 vectors and lysis methodology. Lane M: molecular
weight marker; lane 1: supernatant resulting from the sonication and lane 2: from
detergent lysis of cells expressing the MBP-tagged protein. Lane 3 and 4: soluble
fraction resulting from the sonication and detergent lysis of cells expressing the
GST-tagged protein, respectively.
left to cool to room temperature, and centrifuged. The supernatant was
reapplied to the MBPTrap™ in order to remove the MBP. truncTmaDAH7PS
was eluted in the flow through and was further purified by SEC. Fractions
from SEC containing truncTmaDAH7PS were pooled, concentrated and due
to persistent contamination of MBP, reloaded to a MBPTrap™ to remove
any remaining MBP-tag (Figure 3.5). Fractions containing truncTmaDAH7PS
were pooled, concentrated, flash frozen and stored at −80℃.
3.4.3 Cleavage of the MBP-tag
Due to the incomplete cleavage of the His-tag observed for truncTmaDAH7PS
expressed in the pET151/D-TOPO® vector, cleavage of the MBP-tag by TEV
was assessed (Figure 3.6). Time trials revealed a majority of the cleavage
occurred during the first hour, however only partial cleavage (approximately
50 percent) was ever achieved suggesting inaccessibility of the TEV recognition
site or a high affinity association of MBP and truncTmaDAH7PS.
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Figure 3.5: SDS-PAGE analysis of the final MBPTrap™ purification step of
truncTmaDAH7PS. Pooled fractions of truncTmaDAH7PS collected from SEC were
applied to a MBPTrap™ to try and eliminate the persistent contaminating cleaved
MBP-tag. truncTmaDAH7PS eluted in the flow through of the wash plate and the
MBP-tag in the eluant plate fractions.
Figure 3.6: SDS-PAGE analysis of cleavage of MBP from truncTmaDAH7PS by
TEV protease. Lane M: molecular weight marker; lane 1: truncTmaDAH7PS before
incubation with TEV protease; lane 2: truncTmaDAH7PS after incubation with
TEV for 1 h; lane 3: 2 h; lane 4: 3 h and lane 5: 4 h.
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3.5 Confirmation of Molecular Weight
The molecular weight of truncTmaDAH7PS was 29885.9± 0.2Da as determined
by electrospray mass spectrometry. This is in close agreement with the
29880Da molecular weight calculated from the 268 amino acid open reading
frame coding for truncTmaDAH7PS and the three amino acid residues (Gly,
Ser and Phe) left at the N terminus following cleavage of the MBP-tag.
3.6 Kinetic Parameters
The steady-state kinetic parameters for truncTmaDAH7PS were measured by
following the disappearance of PEP absorbance, spectrophotometrically, at
232 nm and 60℃. Initial velocity rates were calculated with the concentration
of one substrate fixed while the other substrate concentration was varied.
The apparent Km values for E4P and PEP were 38 ± 3µM and 6.6 ± 0.5µM
respectively, and the kcat value was calculated as 18.2 ± 0.3 s−1.
Compared to the full length wild-type protein, truncTmaDAH7PS has
higher KE4Pm and KPEPm values (refer to Chapter 2, Section 2.5). Intriguingly,
this mutant protein was more active than wild-type TmaDAH7PS. The
kcat value for truncTmaDAH7PS is 1.6-fold higher than the kcat observed for
wild-type TmaDAH7PS (11.7 ± 0.2 s−1).
3.7 Metal Activation
Consistent with wild-type TmaDAH7PS, truncTmaDAH7PS also requires a
divalent metal ion for catalysis,64 although there are some small differences
in the activation by different metal ions when compared to the activation
of the wild-type enzyme. To avoid metal contamination, substrate solutions
used in metal reactivation studies were pretreated with Chelex® resin, an
exchange resin that removes polyvalent metal ions, prior to use. Addition
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Figure 3.7: Extent of reactivation of truncTmaDAH7PS (patterned bars) by
various divalent metal ions in comparison with wild-type TmaDAH7PS (plain bars).
Error bars represent the standard deviation.
of 10µM EDTA to the buffer abolished enzyme activity. Catalytic activity
of the apo-enzyme could be restored by addition of 100µM Zn2+, Mn2+,
Co2+, or Cd2+, with Cd2+ resulting in the fastest reaction rates (Figure 3.7).
The most activating metal ion for wild-type TmaDAH7PS was Mn2+. To
enable direct comparison with wild-type, this metal ion was also used for the
characterisation of truncTmaDAH7PS.
3.8 Feedback Inhibition
The degree of sensitivity of truncTmaDAH7PS towards Phe, Tyr and Trp was
investigated. The inhibitory effect of the three amino acids was tested at
increasing concentrations. In marked contrast to wild-type TmaDAH7PS, the
presence of the aromatic amino acids had no effect on the catalytic activity
of truncTmaDAH7PS (Figure 3.8).
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Figure 3.8: Activity remaining in the presence of the aromatic amino acids
(300 µM) for truncTmaDAH7PS (patterned bars) in comparison to wild-type
TmaDAH7PS (plain bars). Error bars represent the differences in measured values.
3.9 Crystallisation and Structure
3.9.1 Crystallisation Trials
The structure of truncTmaDAH7PS was sought to investigate any changes in
protein structure compared to the wild-type enzyme. Crystallisation trials
were performed at the Collaborative Crystallisation Centre (hosted by CSIRO)
at 293K. Initial screens were set up using the sitting-drop vapour diffusion
method. The best diffracting crystal grew from a reservoir solution containing
8% (w/v) PEG 4000, 0.1M sodium acetate, pH 4.6 and 0.02% (w/v) sodium
azide (Figure 3.9).
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Figure 3.9: Crystals of truncTmaDAH7PS that provided the best diffraction.
3.9.2 Structure
truncTmaDAH7PS crystallised in the space group P212121 (Table 3.1). The
two monomers in the asymmetric unit show close structural alignment (RMSD
of 0.15Åi) and associate to form a dimer. The dimer interface, which bur-
ies approximately 13 percent of the solvent accessible surface area of each
monomer, lies on an approximate two-fold rotation axis and includes helices
α6, α7 and α8 and the β6-α6 loop.
The truncTmaDAH7PS dimer in the asymmetric unit is very similar to
the equivalent dimer in the tetrameric wild-type enzyme (PDB code 1RZM,
RMSD of 0.54Å, Figure 3.10a and 3.10c). However, apart from the missing
regulatory domain, the notable difference between truncTmaDAH7PS and
TmaDAH7PS is the variation in quaternary structure in the crystal structure;
truncTmaDAH7PS is dimeric, whereas the wild-type protein is tetrameric,
with the tetramer formed by the interaction of helices (α5, α6, α7 and α8) and
loops (β5-α5, β6-α6 and β7-α7) at the C-terminal end of the barrel.39
The truncTmaDAH7PS dimer overlays closely with the naturally trun-
cated PfuDAH7PS structure (PDB code 1ZCO, RMSD of 0.73Å). Unlike the
engineered truncTmaDAH7PS, PfuDAH7PS is tetrameric in its crystal form,
although it has been predicted to be dimeric in solution.48 Native PAGE
analysis of truncTmaDAH7PS under non-denaturing conditions indicates it
adopts the same quaternary structure as PfuDAH7PS (Figure 3.11).
i All RMSD values hereafter are calculated between equivalent Cα atoms.
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Table 3.1: Crystal parameters, data collection, and refinement statistics for
truncTmaDAH7PS
truncTmaDAH7PS
Data collection
Space group P212121
Cell dimensions
a, b, c (Å) 53.5, 55.5, 166.9
α, β, γ (°) 90.0, 90.0, 90.0
Resolution range (Å) 38.57–2.00 (2.05–2.00)a
Rmergeb 0.067 (0.293)
I/σ(I ) 6.8 (2.0)
Completeness (%) 94.5 (96.3)
Redundancy 3.7 (3.7)
Refinement
No. of reflections 120147
Rwork/Rfreeb 0.155/0.209
No. of atoms
Protein 4008
Ligand/ion 45
Water 238
B-factors (Å2)
Protein 29.5
Ligand/ion 50.4
Water 39.2
RMSD
Bond lengths (Å) 0.006
Bond angles (°) 0.995
Ramachandran
Most favoured (%) 98.4
Allowed (%) 1.0
Disallowed (%) 0.6
PDB code 3PG8
aValues in parentheses are for the highest resolution shell.
bRmerge=
∑
h
∑
i |Ii(h)− 〈I(h)〉| /∑h∑ iIi(h) and is provided by SCALA.
r =∑ ‖Fobs|−|Fcal‖ /∑ |Fobs|, where Fobs and Fcal are the observed and calculated
structure-factor amplitudes, respectively for the working set (Rwork) and test set
(Rfree) of reflections and are provided by REFMAC5.
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(a) (b)
(c)
Figure 3.10: Structure of truncTmaDAH7PS. (a) truncTmaDAH7PS monomer
(red) overlaid with wild-type TmaDAH7PS (PDB code 1RZM) monomer (blue with
the regulatory domain in grey) (RMSD of 0.33Å). (b) truncTmaDAH7PS dimer
(red). (c) truncTmaDAH7PS dimer overlaid with TmaDAH7PS tetramer (blue with
the regulatory domains in grey) (RMSD of 0.72Å).
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Figure 3.11: Non-denaturing PAGE analysis of truncTmaDAH7PS, PfuDAH7PS
and wild-type TmaDAH7PS. Lane M: molecular weight marker; lane 1:
truncTmaDAH7PS; lane 2: PfuDAH7PS; and lane 3: wild-type TmaDAH7PS.
3.10 Small Angle X-ray Scattering
Small angle X-ray scattering (SAXS) was employed to further verify the
quaternary structure of truncTmaDAH7PS in solution. For the scattering
profile of truncTmaDAH7PS, the radius of gyration (Rg), as determined by
Guinier analysis, was 32.2 ± 0.3Å (Figure 3.12b). The pair distribution
function (P(r)) was determined using the indirect Fourier transform method125
and calculated the Rg to be 32.2 ± 0.2Å and the maximum scattering particle
(Dmax) was approximately 90Å (Figure 3.12c). This is similar for those values
calculated for the tetrameric wild-type TmaDAH7PS crystal structure with
the regulatory domain truncated from each of the monomers (truncation of
residues 1–71 for all monomers), with a calculated Dmax of approximately
91Å. There is a notable difference when comparing these values to those
calculated for the dimeric crystal structure of truncTmaDAH7PS (PDB code
3PG8, Dmax value of approximately 85Å).
The differences are more apparent on direct comparison of the CRYSOL
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(a)
(b) (c)
Figure 3.12: SAXS measurements of truncTmaDAH7PS. (a) Theoretical scat-
tering profiles were generated from crystallographic coordinates of both the di-
meric truncTmaDAH7PS (—) and the tetrameric wild-type TmaDAH7PS with
the regulatory domain truncated (residues 1–71) from all monomers (—), using
CRYSOL. These theoretical plots were compared with the experimentally determ-
ined truncTmaDAH7PS data (◦). (b) A Guinier plot was linear for s · Rg < 1.3 for
data collected and (c) P(r) function calculated from truncTmaDAH7PS SAXS data
was calculated using GNOM.125 Uncertainty in P(r) propagated from the I (s) vs
s profile is indicated by error bars.
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fits (Figure 3.12a). The scattering data are a better fit with the theoretical
profile calculated for a truncated tetramer of TmaDAH7PS (PDB code 1RZM),
created by deletion of residues 1–71, than with the dimeric crystal form
(PDB code 3PG8) when analysed with CRYSOL (χ2ν of 0.2 and χ2ν of 34.2,
respectively). This clearly suggests that at the concentrations used in the
SAXS analysis, truncTmaDAH7PS adopts a tetrameric quaternary structure
in solution, which is in contrast to the result obtained from PAGE non-
denaturing gel analysis (Figure 3.11). This suggests the truncated enzyme
exists in a dimer-tetramer equilibrium, that has a K 4 → 2d significantly lower
than the protein concentration used in SAXS experiment.
3.11 Discussion
Removal of the N-terminal domain of TmaDAH7PS generates a protein that is
an efficient catalyst, yet insensitive to Phe and Tyr, conclusively demonstrat-
ing that this domain is required for the inhibition observed for the wild-type
protein.64 Furthermore, truncTmaDAH7PS has a higher catalytic efficiency
than the wild-type enzyme. This phenomenon of higher catalytic activity
by removal of putative regulatory domains has been noted for a number
of enzymes including the dual specificity kinase, CLK1,126 rice glutamate
decarboxylase127 and d-3-phosphoglycerate dehydrogenase,128 suggesting that
regulatory domains recruited by these enzymes act to conformationally con-
strain catalytic activity.126,129 The increased catalytic activity observed for
truncTmaDAH7PS implies that there is a catalytic penalty associated with
the presence of the regulatory domain.
In crystal form, truncTmaDAH7PS is dimeric, unlike the tetrameric
wild-type enzyme, suggesting that the extra domain helps maintain both
quaternary structure and allosteric mechanism. However, different techniques
of measurement suggest that tetrameric species of truncTmaDAH7PS are
indeed possible. But the real question is what is the nature of the dimer-
tetramer equilibrium and associated stabilities in physiologically relevant
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conditions? This highlights the importance of highly accurate techniques such
as analytical ultra centrifugation (AUC), and in particular sedimentation
equilibrium AUC, for the determination and quantification of oligomeric
species in equilibrium.
Interestingly, the dependence of quaternary structure on regulatory
domains has been investigated for the first enzyme in the Ser biosynthetic
pathway, d-3-phosphoglycerate dehydrogenase (PGDH).128 PGDH is a ho-
motetramer that is allosterically regulated by Ser. It was hypothesised that
removal of the regulatory domain would create an enzyme mimic of the unreg-
ulated closely related dimeric enzymes, the d-2-hydroxyacid dehydrogenases.
Truncation of the regulatory domain of PGDH eliminated feedback inhibition
by Ser, but did not result in a change from tetrameric to dimeric quaternary
structure. In mammals, Ser feedback has been replaced by transcriptional
control yet sequence alignments from a variety of species show retention
of the regulatory domain. From these observations it has been suggested
that the regulatory domain of PGDH also functions to provide additional
stability to quaternary structure. However from the observation of the dimer
in the crystalline form of truncTmaDAH7PS, it appears that removal of the
regulatory domain may be sufficient to disrupt quaternary structure.
Having confirmed that the extra N-terminal domain of the type Iβ
TmaDAH7PS is essential for allosteric regulation, several key questions are
evident. What is the mechanism used by this enzyme for regulation? Where
does the inhibitor bind? And, how does ligand binding transmit the inhibitory
signal?
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Chapter 4
Structural Characterisation of
Type Iβ Thermotoga maritima
DAH7PS
4.1 Introduction
Having established that the N-terminal domain of TmaDAH7PS is required
for allosteric regulation, the key questions are how does this extra domain
element foster the regulation of this enzyme, and where do the ligands bind?
This chapter describes the crystallisation and crystal structure determination
of the Tyr-bound TmaDAH7PS.
The structure of wild-type TmaDAH7PS had been previously determ-
ined, and the monomer consists of a catalytic barrel with an N-terminal
extension, described as a FL domain.39 However, this domain has a remark-
able resemblance to an ACT domain (Figure 4.1), a structural motif found in
enzymes responsible for amino acid biosynthesis, for the purpose of ligand
binding.130,131 This motif was first discovered in 1999,132 when a search of a
diverse set of proteins noted to be involved in amino acid or purine biosyn-
68
(a) (b)
Figure 4.1: Structural alignment of the N-terminal regulatory domain of
TmaDAH7PS (blue) with the C-terminal regulatory domain of (a) ATP phos-
phoribosyltransferase (red) (PDB code 1NH8, RMSD of 4.59Å for equivalent Cα
atoms) and (b) the C-terminal regulatory domain of phosphoglycerate mutase
(yellow) (PDB code 1PSD, RMSD of 4.48Å).
thesis and regulated by specific amino acids, recognised this recurring motif.
The proposed domain was named the ACT domain after the first letters of
three of the proteins in which it was originally identified: aspartate kinase,
chorismate mutase and tyrA (prephenate dehydrogenase). The first structure
of an ACT domain was determined in 1995 with the crystal structure of E.
coli d-3-phosphoglycerate dehydrogenase.133
4.2 Crystallisation Trials
As extensions to the core catalytic barrel of the DAH7PS enzymes have
been shown to facilitate allosteric control of catalytic activity, it has been
suggested that the N-terminal extension of TmaDAH7PS is required for
allosteric control of this enzyme.64 In order to shed light on the mechanism
for allosteric regulation, attempts were made to crystallise TmaDAH7PS in
the presence of its most potent inhibitor, Tyr, as no ligand-bound structure
of the type Iβ DAH7PSs had been solved before these studies.
Crystallisation trials were performed at the Collaborative Crystallisation
Centre (hosted by CSIRO) at 293K. Diffracting crystals were obtained from
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a reservoir solution containing 20% (w/v) polyethylene glycol 3350, 0.2M
ammonium nitrate, and 0.02% (w/v) sodium azide (Figure 4.2).
Figure 4.2: Crystals of TmaDAH7PS co-crystallised with Tyr
4.3 Structure of TmaDAH7PS in Complex
with Tyr
Diffraction data from a crystal in Figure 4.2 were collected at the Australian
Synchrotron and solved by molecular replacement in the space group P21.
The asymmetric unit contains eight monomers that display close structural
alignment (maximum RMSD of 0.26Å). The TmaDAH7PS monomer consists
of an N-terminal regulatory domain with a βαββαβ fold (or ACT domain)
arranged as a four-stranded antiparallel β-sheet with two α-helices (residues
1–63), tethered by a flexible linker region (residues 64–93) to the catalytic
(β/α)8-barrel domain (residues 94–338).
The Tyr-bound structure is tetrameric (Figure 4.3) and the eight mono-
mers in the asymmetric unit form two independent tetramers each of approx-
imately 222 symmetry. These tetramers show close structural correspondence
with respect to each other (RMSD of 0.43Å). The loops extending from the
C terminus of the barrel (β2-α2, β3-α3, β4-α4, β5-α5, and β6-α6), the α5 helix,
and the C-terminal end of the α4 helix associate, burying approximately seven
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Table 4.1: Crystal parameters, data collection, and refinement statistics for
wild-type TmaDAH7PS-Tyr complex
TmaDAH7PS-Tyr
complex
Data collection
Space group P21
Cell dimensions
a, b, c (Å) 81.6, 121.0, 133.4
α, β, γ (°) 90.0, 92.1, 90.0
Resolution range (Å) 52.57–2.35 (2.43–2.35)a
Rmergeb 0.102 (0.528)
I/σ(I ) 6.0 (2.0)
Completeness (%) 97.4 (98.6)
Redundancy 3.0 (3.0)
Refinement
No. of reflections 104678
Rwork/Rfreeb 0.171/0.222
No. of atoms
Protein 20456
Ligand/ion 127
Water 565
B-factors (Å2)
Protein 40.9
Ligand/ion 30.4
Water 40.6
RMSD
Bond lengths (Å) 0.003
Bond angles (°) 0.654
Ramachandran
Most favoured (%) 97.7
Allowed (%) 1.8
Disallowed (%) 0.5
PDB code 3PG9
aValues in parentheses are for the highest resolution shell.
bRmerge=
∑
h
∑
i |Ii(h)− 〈I(h)〉| /∑h∑ iIi(h) and is provided by SCALA.
r =∑ ‖Fobs|−|Fcal‖ /∑ |Fobs|, where Fobs and Fcal are the observed and calculated
structure-factor amplitudes, respectively for the working set (Rwork) and test set
(Rfree) of reflections and are provided by REFMAC5.
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(a)
(b)
Figure 4.3: Tyr-bound structure of TmaDAH7PS (a) looking down on, and (b)
side-on to the tetramer. Tyr molecules are shown as spheres, with the carbon
atoms coloured cyan. Each chain has been assigned a different colour.
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percent of the surface area of the barrel to form the tetramer. As is the case
for all (β/α)8-barrel enzymes, the active site is located at the C-terminal end
of the barrel. The arrangement of the monomers in the tetramer results in
alternating active sites around the tetramer so that the diagonally opposite
active sites face the same side of the tetramer plane.
In addition to the contacts between the barrels in the Tyr-bound tetra-
mer, which correspond closely with those observed for the Tyr-free structure,
there is significant interaction between the diagonally opposed N-terminal
regulatory domains, where the anti-parallel β-sheets of diagonally opposite
regulatory domains face each other in their altered position (Figure 4.3a).
The regulatory domain and linker regions from diagonally opposite monomers
interact with each other through hydrogen bonds between His29 and Ser31,
Glu35 and Arg46, and Arg36 and Glu75.
The regulatory domain, in its altered position in the Tyr-bound structure,
also makes contact with residues of the β8-α8 loop at the C-terminal end of
the adjacent barrel, through hydrogen bonds between the main-chain NH
of Asp51 to the O2 of Asp309, carbonyl oxygen of Ser55 to Nη1 of Arg277,
(a) (b)
Figure 4.4: Hydrogen-bonding interactions between the regulatory domain and
C-terminal end of adjacent barrel in the Tyr-bound structure of TmaDAH7PS (a)
looking down on the tetramer, and a (b) close-up view.
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(a) (b)
(c)
Figure 4.5: Structure of the Tyr binding site when in complex with TmaDAH7PS.
(a) Interactions of regulatory domains of diagonally opposite molecules of the
tetrameric TmaDAH7PS. Tyr is shown as cyan sticks. (b) Electron density (2Fo−
Fc’ contoured at 1σ(blue); Fo− Fc’ contoured to 3σ (green); Fo− Fc’ contoured to
−3σ (red) showing Tyr binding between regulatory domains of opposing monomers
and (c) stereo view. Residues contributed by the regulatory domains of different
monomers are coloured either magenta or blue.
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Figure 4.6: Stereo view of the Tyr binding site. Residues contributed by the
regulatory domains of different monomers are coloured either magenta or blue.
Hydrogen-bonding interactions are indicated by dashed lines.
Asp57 to the main-chain NH of Glu304, and for some subunits, between the
side chain of Ser55 to the carbonyl oxygen of either Glu304 or Pro303 (Figure
4.4).
An omit map generated during structure refinement prior to adding the
Tyr molecules to the model, clearly suggests that Tyr is bound. In addition,
the refined electron density for the Tyr molecules was very well resolved
(Figures 4.5b and 4.5c).
In addition to direct contacts, the two Tyr molecules provide further
interactions between diagonally opposed regulatory domains by forming
hydrogen bonds with residues of both domains (Figure 4.5 and 4.6).
Four Tyr molecules are bound per TmaDAH7PS tetramer. The carbox-
ylate functionality of Tyr is bound by hydrogen-bonding interactions between
the main-chain amide of residues Gln34, Glu35 and Arg36 (located in the
β2r-β3r loop of the regulatory domain) of the same monomer, and to the
main-chain amide of Gly43 of the regulatory domain of the opposing monomer
(Figures 4.5a and 4.6).
In addition, the amino functionality of the bound Tyr hydrogen bonds
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with the main-chain carbonyl oxygens of both Ile41 and Gly43 and to Asp45
Oδ1. There are also several hydrophobic chains that approach within 4Å of
the Tyr phenyl ring, including Val38, and Ile42 and Val65 of the opposing
monomer. The phenolic hydroxyl group of Tyr hydrogen bonds to Ser31
(distance of 2.6Å), providing a molecular explanation for the increased potency
of Tyr over Phe as an allosteric inhibitor.
4.3.1 Comparison of the Ligand-free and Tyr-bound
TmaDAH7PS Crystal Structures
The striking difference between the Tyr-bound and ligand-free structures is in
the position of the regulatory domain relative to the tetramer formed by the
catalytic barrels, which is obvious when the structures are overlaid (Figure
4.7a).
In the Tyr-free structure, the regulatory domains from different mono-
mers do not interact. In the presence of Tyr, these domains are repositioned
via a large rotation (approximately 114◦). Specifically, residues Val65, Leu66
and Lys67 are responsible for the deviation of the main chain in the flexible
linker region (Table 4.2).
The consequence of this large displacement of the regulatory domains is
that in the Tyr-bound structure, the regulatory domains effectively cap the
C-terminal ends of the barrels that house the active sites (Figure 4.7b). This
Table 4.2: Phi (φ) and psi (ψ) angles of the residues in the flexible linker region
of TmaDAH7PS in the absence and presence of Tyr
Residue Non Tyr-bound Tyr-bound
φ ψ φ ψ
Val65 −100 97 −106 −52
Leu66 −63 20 −80 147
Lys67 −126 153 −71 141
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(a)
(b) (c)
Figure 4.7: Comparison of Tyr-bound (coloured purple) and Tyr-free (coloured
green) TmaDAH7PS structures revealing major domain reorganisation on Tyr
binding. (a) An overlay of the Tyr-bound and Tyr-free monomer. An overlay
of Tyr-bound and Tyr-free tetramer looking (b) down on and (c) side on, at the
tetramer.
closed structure occludes the active site of each barrel to substrates, thereby
inhibiting the enzyme. In the absence of Tyr, the protein adopts an open
conformation, and substrates can access the active site.
A comparison of the catalytic barrel regions of liganded and unliganded
TmaDAH7PS reveals little overall difference between the two structures
(RMSD of barrel domains is 0.27Å). However, there are some changes in
the loops on the C-terminal end of the barrel that contribute to substrate
binding. On Tyr binding the β2-α2 loop, responsible for the binding of E4P is
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displaced relative to its position in the Tyr-free structure and becomes poorly
defined. This suggests that there may be greater conformational flexibility in
this part of the active site when Tyr is bound to the regulatory domain. This
is consistent with kinetic data, which suggests E4P binding is weakened in
the presence of Tyr.
Intriguingly, the closed form of the enzyme observed in the Tyr-bound
structure is also observed in a structure of TmaDAH7PS deposited in the PDB
by the Joint Centre for Structural Genomics (PDB code 1VR6). This protein
was expressed with a non-cleavable N-terminal His-tag. A comparison of this
structure with that of the Tyr-bound structure determined in these studies,
indicates that this extension at the N terminus has resulted in the elongation
of both β1r and β2r with His (−1 and −3) contributing to interactions with
the opposing regulatory domain, inadvertently locking the protein in the
closed Tyr-bound conformation (Figure 4.8).
4.4 Small Angle X-ray Scattering
SAXS experiments were employed to assess the solution structure of Tma-
DAH7PS in comparison to the crystal structures, and to assess the conform-
ational changes upon Tyr binding. Scattering data were collected in the
presence and absence of Tyr (Figure 4.9).
For the scattering profile in the absence of Tyr, the radius of gyration,
(Rg), as determined by Guinier analysis, was 34.1 ± 0.1Å (Figure 4.10a).
The pair distance distribution function P(r) was calculated using the indirect
Fourier transform method. The Rg from the P(r) analysis was calculated to
be 33.4 ± 0.1Å and the maximum dimension of the scattering particle (Dmax)
was approximately 97Å (Figure 4.10c), which is in close agreement with the
open Tyr-free crystal structure (PDB code 1RZM, Dmax is approximately
99Å). These scattering profile data for wild-type TmaDAH7PS are consistent
with the tetrameric form of the protein observed in the crystal structure and
predicted for the protein in solution.39,64
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Figure 4.8: Regulatory domain associations in His-tagged TmaDAH7PS (PDB
code 1VR6). Domains from diagonally opposite regulatory domains in the tetramer
are coloured yellow and orange. Water molecules are shown as red spheres.
In the presence of Tyr the Rg, as determined by Guinier analysis, was
32.8 ± 0.1Å (Figure 4.10b). The Rg from the P(r) analysis was calculated
to be 32.0 ± 0.1Å and the Dmax was approximately 95Å (Figure 4.10d).
Again, this is in close agreement with the Tyr-bound, closed crystal structure
(approximately 92Å). Taken together, the solution SAXS data suggest in the
presence of Tyr TmaDAH7PS has a more compact structure than it adopts
in the absence of Tyr, a result that is entirely consistent with the crystal
structures.
Direct comparisons were made of the open and closed crystal struc-
tures to the solution SAXS data using CRYSOL134 and OLIGOMER.135
OLIGOMER fits an experimental scattering curve from a multicomponent
mixture, in this case the open and closed forms of TmaDAH7PS, to find the
fraction of each component present in the sample. In the absence of Tyr,
79
(a)
(b)
Figure 4.9: SAXS measurements of TmaDAH7PS, with and without Tyr. Theor-
etical scattering profiles were generated by using the crystallographic coordinates
of both the Tyr open structure (PDB code 1RZM, short dots), and the Tyr-bound,
closed structure (PDB code 3PG9, short dashes) using CRYSOL. These theoretical
plots were compared to the experimentally determined TmaDAH7PS data (◦) in
both the (a) absence and (b) presence of Tyr. The experimental SAXS data were
fitted to a distribution of both the open and closed forms using OLIGOMER (solid
line). χ2ν values for the fit to the calculated CRYSOL data for the open (1RZM)
and closed (3PG9) conformations and values for the OLIGOMER fit for the data
in (a) are 0.48, 11.4 and 0.38 respectively, and the values for (b) are 11.0, 1.31, and
0.71.
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(a) (b)
(c) (d)
Figure 4.10: Guinier plots and P(r) function calculated for TmaDAH7PS in the
presence and absence of Tyr. Guinier plots were linear for s · Rg < 1.3 for data
collected in the (a) absence and (b) presence (b) of Tyr. P(r) function calculated
using GNOM125 from TmaDAH7PS SAXS data (c) without and (d) with Tyr.
Error bars indicate uncertainty in P(r), propagated from the I (s) vs s profile.
the scattering profile largely fits that calculated for the open TmaDAH7PS
crystal structure (PDB code 1RZM) when analysed with CRYSOL (reduced
chi-squared (χ2ν) of 0.48, Figure 4.9a). However, analysis with OLIGOMER
predicts that approximately ninety percent of the protein adopts the open
form, and approximately ten percent adopts the closed form (χ2ν of 0.38). The
OLIGOMER fit to this mixture represents a statistically better fit to the data
than a fit to the CRYSOL profile generated from the open structure alone
(PF(F;ν1,ν2 )<0.05). This analysis is consistent with both open and closed
forms of the protein being accessible to the unliganded protein. It is likely
that the protein exists as a conformational ensemble, including intermediate
conformations between the open and closed conformational extremes observed
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in the X-ray crystal structures.
There is a distinct difference in the scattering profile of TmaDAH7PS
when Tyr is present (Figure 4.9). Here, the scattering data fit more closely
to the theoretical profile calculated for the closed, Tyr-bound structure
when analysed with CRYSOL (χ2ν of 1.3). However, a better fit is obtained
once again when the data are analysed with OLIGOMER, which predicts
that approximately eighty percent of the protein is present as the closed,
inactive form and approximately twenty percent is in the open and active
form (χ2ν of 0.70). When compared with the CRYSOL fit to the closed Tyr-
bound structure, again the fit of the experimental data to the OLIGOMER
prediction is statistically better (PF(F;ν1,ν2 )<0.05). The mixture of open
(approximately twenty percent) and closed (approximately eighty percent)
forms suggested by the scattering of TmaDAH7PS in the presence of Tyr,
is consistent with the Tyr inhibition results (Figure 2.4), showing that the
enzyme displays partial inhibition with respect to Tyr.
These solution SAXS data clearly corroborate the two distinct conforma-
tions observed for wild-type TmaDAH7PS in the crystal structures. Moreover,
the data indicates that Tyr binding favours the adoption of the closed con-
formation for TmaDAH7PS; that is, it latches the regulatory domain into a
position that occludes the active site of the adjacent subunit.
4.5 Discussion
The ability to regulate enzymic function is essential for controlling metabolism.
As advances towards understanding the finer detail of molecular structure are
occurring, alongside is the discovery of the mechanisms of enzyme catalysis.
Numerous mechanisms have been reported that confer regulation via ligands
binding remotely to active sites.136 This variety is well demonstrated by the
enzyme catalysing the first reaction on the way to aromatic compounds,
namely DAH7PS. These mechanisms differ significantly from the subtle
synergistic inhibition observed in MtuDAH7PS,66,106 where a combination of
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Figure 4.11: Schematic representation of regulatory domain shift of TmaDAH7PS
on Tyr binding. Tyr (green triangle) binding results in a major structural reorgan-
isation so that the regulatory domains of diagonally opposite molecules occlude the
active site (black shading) of the neighbouring barrel. The barrel of each monomer
is represented by a circle and the regulatory domain as a rectangle.
the binding of two aromatic amino acids results in minimal structural changes,
to the substantial domain reorganisation exhibited by TmaDAH7PS in these
studies.
For TmaDAH7PS, the (β/α)8 barrel housing the core catalytic machinery
is fused at the N terminus to a distinctive domain with a βαββαβ fold. This
domain fold is remarkably similar to the ACT domain, which has been
acquired, through gene fusion, by a number of other enzymes involved in
amino acid biosynthesis for the purpose of conferring regulation.130,137
The structure of TmaDAH7PS, determined in the presence of Tyr,
reveals pairs of Tyr molecules on each side of the tetramer, nestled in bind-
ing sites formed by pairs of regulatory domains that extend from different
monomers. Sequence alignments suggest that the regulatory domain of Tma-
DAH7PS is found in a number of other DAH7PS enzymes, indicating that
fusion to this domain is a general mechanism for the acquisition of allosteric
control by this enzyme.
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The molecular details of the allosteric mechanism are evident from
structural studies of TmaDAH7PS in the presence and absence of Tyr in
both crystal and solution forms. Inhibition mediated by Tyr is shown to
be associated with a considerable reorganisation of the structure of the
enzyme. The enzyme can adopt both an open form, where the regulatory
domains extending from each monomer of the tetrameric protein show no
association, or a closed form, in which the C-terminal end of the barrel
housing the active site is capped, and substrate access is restricted. A
dynamic equilibrium between the open and closed forms exists. Tyr perturbs
the position of this equilibrium, effectively latching the swinging regulatory
gate into the closed position (Figure 4.11). In the unliganded open form,
transient associations result in the potential for the regulatory domains to
interact. These interactions may help stabilise quaternary structure and
provide a clue to why truncTmaDAH7PS is dimeric in crystalline form.
Although the gross domain reorganisation observed on Tyr binding for
TmaDAH7PS shown in this study appears to be far more dramatic than the
more subtle movements associated with allosteric control of other proteins,
there are some parallels with other systems.138,139 As more structural studies
reveal the details of both liganded and unliganded forms of proteins, it seems
likely that similar strategies for allosteric control will be uncovered. What
is becoming clear is: (1) that ACT domains typically combine; (2) that
ligand-binding sites are frequently provided at the interfaces between two or
more ACT domains; and (3) that associations between these domains are
integral to the mechanisms of allosteric control. For example, binding of
histidine to ATP phosphoribosyl transferase, the enzyme that catalyses first
committed step of histidine (His) biosynthesis, results in perturbation of the
equilibrium position between active dimeric and inactive hexameric forms.
This change is mediated via interactions between ACT domains.138 Likewise,
tetramerisation of the P-protein (with chorismate mutase and prephenate
dehydratase activities) involves regulatory ACT domains and is associated
with enzyme inhibition.139 It has been suggested that alteration in quaternary
interactions may prove to be a general mechanism for allosteric control for
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proteins that bear this regulatory extension.130
The quaternary structure of TmaDAH7PS is essential for allosteric con-
trol. There are significant interactions across the tetramer interface when the
protein adopts the closed conformation, not only between adjacent monomers
but also between opposite monomers involving both the catalytic and regu-
latory domains. These studies provide insight into the interactions between
quaternary structure and regulatory extensions that deliver regulated catalysis
of TmaDAH7PS. Regulation is achieved by the abrogation of substrate entry
to the active site and is mediated by a physical gating mechanism controlled
by Tyr binding.
In conclusion, these studies illuminate an intricate interplay between
quaternary structure and regulatory extensions that delivers the regulated
catalysis of this enzyme. Regulation is achieved by a remarkable ligand-
controlled gating mechanism governing substrate access to the enzyme active
site.
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Chapter 5
Investigating the Residues in
Thermotoga maritima
DAH7PS Important for Ligand
Binding and Regulation
5.1 Introduction
The structural and functional characterisation of a truncated variant, lacking
the N-terminal domain (Chapter 3), and the Tyr-bound structure of Tma-
DAH7PS (Chapter 4) have shown that this extra structural motif decorating
the basic (β/α)8 barrel of TmaDAH7PS is essential for allosteric regulation. A
significant conformational change of the tetrameric protein occurs on ligand
binding; whereupon Tyr is bound in a cleft formed between two opposing
N-terminal ACT domains. This ligand-binding site physically obstructs
substrate entry to the active site, impeding the catalytic activity of the
enzyme.
Previous studies of the type Iα DAH7PS subfamily have proposed that
86
Figure 5.1: Surface representation of EcoDAH7PS (PDB code 1KFL) showing
how the N-terminal (red) and internal extension (yellow) together create a binding
cavity for the inhibitor, Phe (cyan, sticks). The specificity determining Ser residue
is shown as green sticks.
specific feedback sensitivity can be predicted by the inspection of primary
sequence.33 This DAH7PS subfamily has two extensions to the core TIM-
barrel structure, which together create a binding cavity for the inhibitor
molecule (Figure 5.1).
It has been proposed that one key residue within this binding cavity
dictates the sensitivity and ultimately defines the specificity of the enzyme to
inhibition by Phe and Tyr.33 Specifically, for the Phe-regulated isozyme of
SceDAH7PS, and all Phe sensitive Iα DAH7PSs, a hydroxyl group is provided
by a conserved Ser residue found at the bottom of the inhibitor-binding
cavity. The smaller conserved Gly residue found in this same position for
the Tyr-regulated isozyme increases the size of the cavity and accommodates
the steric bulk of the Tyr ligand’s hydroxyl group. The single mutation of
Gly-to-Ser in Tyr-regulated DAH7PSs leads to a complete switch in regulatory
ligand specificity without affecting kinetics.33
In the type Iβ TmaDAH7PS enzyme, the assembled regulatory domains
also create an inhibitor-binding cavity, with contributions by residues from
the regulatory domains of two different monomers. To investigate the essential
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Figure 5.2: Hydrogen-bonding interactions (black dashes) of residues His29 (green
sticks) and Ser31 (blue sticks) from opposing regulatory domains with Tyr (yellow
sticks).
binding interactions of Tyr and Phe with TmaDAH7PS, variants were designed
by analysis of the ligand-bound crystal structure of TmaDAH7PS, targeting
residues with side-chain ligand interactions to the bound Tyr.
One of the notable hydrogen-bonding interactions with Tyr in the Tyr-
bound structure of TmaDAH7PS is between the side chain of Ser31 and
the hydroxyl group of the Tyr ligand (Figure 5.2). His29, contributed from
the opposing regulatory domain, hydrogen bonds to the hydroxyl group of
Ser31 and is also in close proximity to the hydroxyl group of the bound Tyr.
Although possibly not directly involved in binding to the inhibitor, His29
may be important for securing the correct orientation of Ser31 or the ligand.
Could a single mutation be enough to change inhibitor specificity in
TmaDAH7PS? Furthermore, is the absolute positioning of His29 and Ser31
important? This chapter describes the investigation into the importance
of key interactions between the inhibitor molecule and the residues of the
enzyme that may impart inhibitor specificity.
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5.2 Choice of Mutations
The mutational changes were chosen based on their interaction with Tyr
and by analogy with the studies of the Iα DAH7PS subfamily, in which
ligand specificity appears to be determined by a single residue.33 Unlike
the Tyr-sensitive Iα DAH7PS enzymes, which have a Gly residue in the
inhibitor-binding cavity, TmaDAH7PS has a Ser residue, similar to the Phe
sensitive enzymes. This Ser residue appears to be important because it forms
a hydrogen bond to the hydroxyl group of Tyr. Ser31 was mutated to Gly
(creating TmaS31G), to remove the specific interaction with Tyr, and to also
eliminate the hydrogen bond to His29 on the opposing subunit.
Although His29 has no direct interaction with Tyr, it is in close proximity
to the ligand and forms a hydrogen bond with Ser31. Mutation of this His
to alanine (Ala) (creating TmaH29A) was designed to remove any hydrogen
bonding capabilities of the residue’s side chain, and replace it with a small
non-intrusive side chain. Analysis of this variant protein may provide insights
into the importance of the interdomain contacts between His29 and Ser31,
and the secondary role His29 may play in assisting with correct placement of
Ser31. Furthermore, to probe the importance of possible hydrogen-bonding
contacts between the two domains, mediated by His29 and Ser31, His29 and
Ser31 were interchanged and the resulting variant (TmaH29S/S31H) analysed
for effect of this substitution on regulation/inhibition.
5.3 Mutagenesis, Expression and
Purification
A QuikChange® Lightning Site-Directed Mutagenesis Kit was used to intro-
duce site-specific variants in the TmaDAH7PS pT7-7 plasmid. Extension
of primers, containing the desired mutations, generated mutated plasmids.
The PCR product was subjected to DpnI digestion, agarose gel analysis
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and transformation into E. coli TOP10 cells. Small cultures of individual
colonies were grown and plasmids extracted. DNA sequencing confirmed
the identity of colonies containing the desired mutations. Plasmids with the
correct sequence were transformed into the protein expression cells E. coli
BL21 Star™(DE3). Cultures were grown, protein expression induced, and
over-expressed protein purified using the same method as was developed for
the purification of wild-type TmaDAH7PS (Chapter 2, Sections 2.2 and 2.3).
5.4 Confirmation of Molecular Weight
The molecular weights of the variants proteins were determined by electrospray
ionisation mass spectrometry, and are in close agreement with the molecular
weights calculated from the amino acid sequence (Table 5.1).
Table 5.1: Expected and experimentally determined molecular weights of
TmaDAH7PS variant proteins
TmaDAH7PS Expected Measured
(Da) (Da)
H29A 37 312 37 311
S31G 37 348 37 348
H29S/S31H 37 378 37 378
5.5 Kinetic Parameters
All three variants were found to be catalytically active and displayed similar
kinetic parameters to those of wild-type TmaDAH7PS. The steady-state
kinetic constants were determined for each of the variants using the same
assay method as was employed for wild-type TmaDAH7PS (Chapter 2, Section
2.5). In comparison to wild-type TmaDAH7PS, the variants all display higher
KPEPm and KE4Pm values despite the mutations being distant to the active site
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Table 5.2: Kinetic parameters for TmaDAH7PS variants
TmaDAH7PS KPEPm (µM) KE4Pm (µM) kcat (s−1)
WT 4.85± 0.04 13± 1 11.7± 0.2
H29A 12.8 ± 0.4 30± 1 17.5± 0.3
S31G 21 ± 2 33± 2 14.3± 0.2
H29S/S31H 39 ± 1 28± 1 14.1± 0.1
(Table 5.2). Interestingly, the variants also show slightly higher kcat values
than wild-type TmaDAH7PS. However, for thermophilic DAH7PS enzymes,
some inconsistencies in kcat values recorded at elevated temperatures have
been previously noted (Schofield, unpublished data).
5.6 Small Angle X-ray Scattering
SAXS was used to investigate whether the conformational change observed on
inhibitor binding for wild-type TmaDAH7PS is also apparent for TmaH29A,
TmaS31G and TmaH29S/S31H. Data were collected in the absence and
presence of Tyr or Phe, and the scattering profiles collected were compared
to the response of wild-type TmaDAH7PS.
The scattering profiles for all proteins were very similar in the absence
of Tyr or Phe, indicating that all variants adopt (in solution) the same overall
fold and tetrameric quaternary structure as wild-type TmaDAH7PS (Figure
5.3a). There appears to be a slight variation in the scattering profile of
TmaS31G, which perhaps is an indication of the open/closed equilibrium
being even more in favour of the open form.
On the addition of Tyr or Phe, significant changes to the scattering
profiles were observed, in particular the scattering around 0.1Å−1 and 0.2Å−1
(Figure 5.3). This change is in line with the profile obtained when Tyr is
added to wild-type TmaDAH7PS, and suggests that in the presence of either
Tyr or Phe, all variants undergo a structural change to acquire a more globular
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(a)
(b)
(c)
Figure 5.3: Comparison of SAXS measurements from TmaH29A (4), TmaS31G
(◦) and TmaH29S/S31H (5), compared to those collected from wild-type
TmaDAH7PS () in the (a) absence of ligand, (b) presence of Tyr or (c) presence
of Phe.
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(a) (b)
(c) (d)
Figure 5.4: SAXS measurements of (a) wild-type TmaDAH7PS, (b) TmaH29A,
(c) TmaS31G, and (d) TmaH29S/S31H comparing SAXS measurements in the
absence of inhibitor (), presence of Tyr (◦) and presence of Phe (4).
closed conformation similar to that adopted by wild-type TmaDAH7PS.
The changes to the scattering profile for TmaH29A in the presence of
Tyr or Phe (Figure 5.4b), mirror closely the changes observed for wild type,
suggesting the presence of these inhibitors at the concentrations employed
elicits a similar degree of conformational change in both proteins. However, for
TmaS31G in the presence of Phe and Tyr, the changes in the scattering profile
are similar but are not as pronounced as the TmaH29A construct. Although
the overall shape adopted by TmaS31G appears to be more globular in the
presence of Tyr or Phe, close analysis of the SAXS measurements reveals
a flatter profile (Figure 5.4c) than for wild-type protein and TmaH29A,
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suggesting this variant adopts a more elongated structure.140 This result
may indicate some impairment to the regulatory domain interaction in this
particular variant.
A similar response to that observed for TmaS31G is also observed for
TmaH29S/S31H (Figure 5.4d). As a dynamic equilibrium is likely to exist
between the open and closed forms of TmaDAH7PS, and as SAXS data are
derived from an average structure in solution, removing the Ser31 hydroxyl
may have disturbed this balance, pushing the protein more towards the
open conformation, resulting in the change observed in the scattering profile.
Generally, the addition of Tyr and Phe to the variant enzymes generate the
same conformational response in solution, however for TmaH29S/S31H a
slight increase in change for Phe over Tyr is apparent.i
5.7 Response to Inhibitors
Table 5.3: Estimated IC50 values for wild-type and variant TmaDAH7PS
TmaDAH7PS Estimated IC50 (µM)
Tyr Phe
WT 20 180
S31G 250 260
H29A 40 100
H29S/S31H 130 150
The degree of sensitivity towards Tyr or Phe for each variant was tested
using increasing concentrations of each inhibitor (Figure 5.5). The analysis of
this inhibition is quite complex and several tools were employed to help gain
insight into the variable responses of these enzymes to inhibitors. The half-
maximal inhibition concentrations (IC50) were calculated using the Logistic
Fit (Origin Pro 8.1) and these values were directly compared to the response
i The P(r) functions and Guinier plots calculated from the variant protein SAXS data
are located in the appendix.
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(a)
(b)
Figure 5.5: Comparison of TmaH29A (4), TmaS31G (◦), TmaH29S/S31H (5)
and wild-type TmaDAH7PS () response to varying concentrations of (a) Tyr and
(b) Phe. Error bars indicate standard deviation. Sigmoidal curves were generated
and estimated IC50 values were determined by fitting the data to the Logistic
Model using OriginPro 8.1.
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of the wild-type protein (Table 5.3). These IC50 values hide the fact that the
total inhibition is greater for some variants at higher ligand concentrations,
therefore for greater clarity the levels of inhibition at 300 µM of inhibitor were
also directly compared (Figure 5.6).
Tyr does not inhibit TmaS31G to the same extent as it inhibits wild-
type TmaDAH7PS. Similarly, TmaS31G is slightly less sensitive to Phe than
the wild-type protein. Notably, the selectivity for Tyr over Phe is all but
abolished, with TmaS31G showing similar levels of inhibition with either
aromatic amino acid. These results reveal the importance of Ser31 for both
sensitivity toward Tyr and inhibitor specificity.
Of the three variants, TmaH29A behaved most similarly to the wild-type
enzyme with a comparable response in the presence of Tyr. However, this
protein shows a significantly increased response to Phe. In fact, Phe is a more
potent inhibitor for TmaH29A than for any of the other proteins. Intriguingly,
this indicates that while sensitivity is not lost, selectivity for Tyr over Phe
was compromised.
TmaH29S/S31H, shares some similarities to TmaS31G, in that inhibition
by Tyr is significantly compromised. Interestingly, this protein was found to
Figure 5.6: Wild-type and variant TmaDAH7PS response to 300µM Tyr (blue)
and Phe (red).
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respond to Tyr and Phe with similar sensitivity.
5.8 Discussion
Some DAH7PS enzymes, including MtuDAH7PS,106 EcoDAH7PS27 and Sce-
DAH7PS33 have a pre-formed ligand-binding cavity and undergo very subtle
structural changes on ligand binding. However, the N-terminal regulatory
domain of TmaDAH7PS, a type Iβ enzyme, undergoes a significant change
in conformation to create a ligand-binding site. Residues from two different
protein chains contribute to ligand binding, and direct inter-subunit contacts
are formed. To elucidate the role of different residues in determining the
sensitivity and selectivity of the allosteric response in TmaDAH7PS, mutations
were created to disrupt key interactions between the protein and bound
inhibitor.
These studies have shown that Ser31 plays a significant role in inhibitor
binding for TmaDAH7PS. This is not the first time a Ser residue has been
shown to be important in the allosteric regulation of a DAH7PS enzyme.141
Although Ser is not charged at physiological pH, the primary OH group is
hydrophilic and forms hydrogen bonds. Due to its ability to act as either a
donor, acceptor group, or both, it is found in diverse electrostatic environ-
ments.142 Hydroxyl groups have a degree of rotational freedom that allows
them to align themselves to minimise the energy of their hydrogen-bonding
interactions. The observed rotamer conformation indicates the predominance
of either the strongest hydrogen-bond formation or the arrangement providing
the lowest steric effect.
The versatility of Ser is evident in the Tyr-bound crystal structure
of TmaDAH7PS where the alcohol containing side chain of Ser31 forms a
hydrogen bond with the hydroxyl moiety of the bound Tyr ligand. Fur-
thermore, Ser31 also forms a hydrogen bond with His29 from the opposing
regulatory domain, which may ensure the correct positioning of Ser31 to bind
Tyr and the correct construction of the binding pocket. Exchange of the
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neutral-polar side chain of Ser31 for the simple hydrogen of Gly, eliminates
the hydrogen-bonding ability of the side chain and severely compromises the
inhibition of TmaDAH7PS by Tyr. Interestingly, this mutation also slightly
decreases the inhibition of TmaS31G by Phe in comparison to the wild-type
enzyme, but Tyr is still more potent than Phe for inhibition of this modified
enzyme. This observation suggests that the hydrogen-bonding capability of
the hydroxyl side chain of Ser31, with the hydroxyl group of the Tyr ligand
and with His29, plays an important role for selection between Tyr or Phe.
Preliminary molecular dynamics results suggest that the replacement of the
hydroxymethyl side chain of Ser with a hydrogen provides sufficient space for a
water molecule to be recruited to hydrogen bond with the Tyr hydroxyl group
(Jiao, personal communication). This may provide a plausible explanation for
the observation that domain closure still takes place, albeit poorly, and that
TmaS31G demonstrates slightly greater sensitivity to Tyr than Phe. The
overall loss of responsiveness towards Tyr and Phe indicates that Ser31 is also
important for the inhibitor sensitivity. Furthermore, the SAXS scattering
profile for TmaS31G indicates that a conformational change similar to that
observed for wild-type occurs on inhibitor binding. However, the change is
more subtle and substantiates the loss of sensitivity towards both Tyr and
Phe.
The ability of TmaH29A to hydrogen bond to Tyr is presumed to be
preserved in this variant by the presence of Ser31. Although the removal of the
imidazole functionality does not appear to affect the enzyme’s responsiveness
to Tyr in comparison to wild-type, a dramatic increase in response to Phe is
observed. In fact, this enzyme shows the highest sensitivity towards Phe of
any of the proteins. This is consistent with the importance of the hydrogen
bond between Ser31 and His29 for inhibition of the enzyme by Tyr, and
suggests that His29 plays a role in determining selectivity towards Tyr. The
increase in sensitivity to Phe is somewhat puzzling. If the hydrogen bond to
Ser31 was important to the hydrogen-bonding network, as suggested by the
S31G variant, one would expect TmaH29A to be similarly impaired. Crystal
structures of these variants with bound ligand may help clarify reasons for
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this apparent anomaly.
It is well established that aromatic residues undergo non-covalent en-
ergetically favourable interactions between side chains of the amino acids
Phe, Tyr, Trp and, although complicated by the positive charge, of His as
well.143 Aromatic-aromatic interactions are prevalent in many areas of chem-
istry.144 Examples include the aggregation of porphyrins,145 conformation of
phenylactetylene macrocycles,146 and the strength of kevlar can be in part
be attributed to aromatic-aromatic interactions.147 In biological chemistry,
aromatic-aromatic interactions are crucially involved in protein DNA com-
plexes where the interactions between aromatic side chains and base pairs
are actually visible in X-ray structures.148,149
Some studies have suggested that phenyl-rings align themselves in a
perpendicular arrangement, whereas others report that pairs or dimers of
aromatic acids prefer to align their respective aromatic rings in an off-centred
parallel arrangement consistent with those found for the benzene dimer (Figure
5.7a).144 Either way, it is obvious that dimers of these residue side chains
have many possible stabilising interactions and at distances larger than the
average van der Waals radii.144 It has been suggested that sixty percent of
aromatic side chains in proteins are found to be involved in aromatic-aromatic
interactions and up to eighty percent of these energetically favourable albeit
weak aromatic-aromatic interactions stabilise protein quaternary structure.150
In the Tyr-bound crystal structure of TmaDAH7PS, Tyr and His29
appear to adopt a T-shaped pi-stacking configuration (Figure 5.7b) and the
loss of this interaction may explain the small reduction in sensitivity towards
Tyr. However, the aromatic-His interactions with Phe or with Tyr have
been reported as being inequivalent, with the interaction of Tyr and His less
stabilising than the Phe-His interaction.151 From this it would be expected
that disturbance of the His-Phe interaction would have a larger effect than
His-Tyr. However, the increase in sensitivity observed in TmaH29A towards
Phe argues against the role of pi-stacking for His29. The significant increase
in sensitivity toward Phe may simply be due to the increased opportunity to
access the ligand-binding site resulting from removal of the steric bulk of the
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(a) (b)
Figure 5.7: (a) Representative conformations of the pi interactions observed in
the (a) benzene dimer compared with the possible equivalent interaction in (b)
wild-type TmaDAH7PS
imidazole side chain of His29. Alternatively, replacement of the slightly polar
His residue with Ala may create a more hydrophobic environment, favouring
binding of Phe.
As hydrogen-bonding interactions will be disturbed by the simultaneous
exchange of His29 and Ser31, a large effect on estimated IC50 values may have
been expected. Unsurprisingly, this mutational pairing severely compromises
selectivity and sensitivity to inhibition by Tyr. Assuming Tyr remains close
to its position in wild-type TmaDAH7PS, analysis of the possible rotamers
accessible in these exchanged positions suggest there is no arrangement that
would permit a hydrogen bond between the hydroxyl group of Tyr and Ser29.
However, a hydrogen bond could be made between the Tyr hydroxyl and
His31 and an extended hydrogen bond between His31 and the main chain of
Ser29 (Figure 5.8).
Nevertheless, inhibition results for TmaS31G and TmaH29S/S31H sug-
gest the hydrogen bond, specifically to the Tyr hydroxyl group, is compromised
in line with the similar abilities of Tyr and Phe to inhibit this variant. These
results are further reflected by the SAXS scattering profiles obtained for these
two variants, in the absence and presence of Tyr and Phe, which show a
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Figure 5.8: Potential hydrogen-bonding interactions of residues His31 (blue sticks)
and Ser29 (green sticks) from opposing regulatory domains with Tyr (yellow sticks).
decreased response to inhibitor-induced conformational change.
Although Ser31 is not conserved across the ACT domain of the Iβ
DAH7PSs that possess this N-terminal extension, mutational studies of Tma-
DAH7PS have shown the importance of this residue for selective Tyr binding.
Subsequent studies to further probe the importance of this residue could
include mutation to an Ala residue. This mutation would eliminate the
hydrogen-bonding capabilities of the residue to the inhibitor and preclude
water from accessing the cavity and acting as a surrogate hydrogen-bonding
partner, therefore allowing a more complete assessment of the importance
of this Ser residue. Phe inhibition appears to be more complicated with a
number of less obvious contributing factors that are yet to be uncovered. A
crystal structure of TmaDAH7PS with Phe bound should be sought to help
with this analysis.
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Chapter 6
Fusion of the Regulatory
(ACT) Domain from a
Regulated DAH7PS to an
Unregulated DAH7PS Barrel
6.1 Introduction
Protein remodelling in order to obtain proteins and enzymes with desirable
properties and activities is a current focus of biotechnology.152 The manipula-
tion of existing protein scaffolds to impart ideal properties can be achieved
by combinatorial methods such as molecular breeding,153 DNA shuffling,154
or the exchange of elements between two or more existing enzymes to create
hybrid enzymes. The elements that can be swapped may be single residues,
secondary elements, subdomains, domains or entire proteins.155
ACT domains are found in a large number of proteins. A majority of
ACT-domain containing proteins appear to interact with amino acids and
are involved in some aspect of regulation of amino acid metabolism.132,156,157
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Increasing diversity in tertiary and quaternary architecture and ligand-binding
interactions are being uncovered for the ACT domain as more structures are
determined. It has been suggested that the recruitment of ACT domains for
the purpose of allosteric regulation can be explained by its ability to create
symmetric or asymmetric assemblies, resulting in a highly diverse array of
binding sites and mechanisms of control.131
Most ACT domains are found within Bacteria and Archaea, which
indicates that appearance of this domain occurred early in evolutionary history,
however there is at least one functional example found in a mammalian protein,
rat phenylalanine hydroxylase.158 There appears to be no distinct consistency
of the use of ACT domains within a particular species or within proteins
that possess a common activity. It has been suggested that the ACT domain
represents a “conserved, evolutionarily mobile module” that when fused to
other proteins, makes them susceptible to regulation by small molecules.132
The recruitment of the ACT domain in the Iβ DAH7PS subfamily is
clear from inspection of structure and sequence. This makes this subfamily the
ideal system in which to explore whether the property of allosteric regulation
is an intrinsic property of the ACT domain itself, encoded entirely by this
domain, or whether an essential interplay exists between the regulatory ACT
domain and DAH7PS catalytic barrel. This chapter will explore the mobility
of the ACT domain from DAH7PS by fusing the ACT domain (derived from
a regulated DAH7PS, TmaDAH7PS) onto an unregulated DAH7PS scaffold
(PfuDAH7PS).
6.2 Choice of Fusion Site
At the commencement of these studies, PfuDAH7PS was the only thermophilic,
unregulated type Iβ DAH7PS enzyme that had been characterised both
functionally and structurally.38,48 Due to the availability of the gene encoding
for PfuDAH7PS, familiarity with the enzyme, and the structural similarity
between the barrel elements of PfuDAH7PS and TmaDAH7PS (Figure 6.1),
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(a) (b)
Figure 6.1: (a) PfuDAH7PS (PDB code 1ZCO) monomer (yellow) superimposed
with the catalytic barrel of TmaDAH7PS (PDB code 1RZM) (blue) (RMSD of
0.539Å) and (b) tetramer overlay (RMSD of 0.520Å).
PfuDAH7PS was chosen as the scaffold for fusion to the regulatory ACT
domain of TmaDAH7PS.
The crystal structures of both TmaDAH7PS and PfuDAH7PS show the
existence of a β-hairpin at the N-terminal end of the barrel. Two constructs of
TmaPfuDAH7PS were designed to preserve the β-hairpin and allow a sufficiently
long linker between the ACT domain and catalytic barrel. Construct 1
incorporated the β-hairpin from PfuDAH7PS, which is slightly shorter than
the equivalent region in TmaDAH7PS. Whereas, construct 2 derived its
linker and β-hairpin from TmaDAH7PS, and thus more closely resembled
TmaDAH7PS. The determination of the ligand-bound crystal structure of
TmaDAH7PS illustrated the importance of the linker for regulation and initial
expression trials revealed construct one was insoluble. Therefore, construct
one was not considered further in these studies.
The selected TmaPfuDAH7PS construct incorporated both the β-hairpin
and the linker located between the catalytic and ACT domains of Tma-
DAH7PS. This linker is thought to enable the conformational rotation of
the ACT domain that occurs on ligand binding for TmaDAH7PS and allows
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Figure 6.2: Primary sequence of the two constructs of the chimeric protein,
TmaPfuDAH7PS, comprising of fusion between the catalytic domain of PfuDAH7PS
and the ACT domain of TmaDAH7PS. The fusion sites for construct 1 (H) and
construct 2 (H) are indicated. α-helices and β-strands of the barrel are highlighted
red and green, respectively. Non-core α-helices are highlighted cyan and non-core
β-strands are coloured yellow. The residues of the TmaDAH7PS barrel, which are
identified as having interactions with the ACT domain on ligand-induced closure,
are highlighted pink.
105
the two domains opportunity to fold correctly to achieve a tertiary structure
without interference from one another.152
6.2.1 Sequence Conservation
Sequence alignment analysis of the barrel region of all type Iβ DAH7PS
enzymes show that the general level of conservation is relatively low with
only nineteen conserved residues across this region. Similarly, alignments
of the ACT domains found within the type Iβ DAH7PSs show only a few
semi-conserved residues. Despite the sequence variation found within the Iβ
subfamily of DAH7PS enzymes, the barrel regions of PfuDAH7PS and Tma-
DAH7PS appear similar in both structure (RMSD of 0.539Å) and sequence,
with 166 conserved residues or 63 percent identity (Figure 6.2). Hence,
the choice of PfuDAH7PS and TmaDAH7PS as fusion partners potentially
parallels the domain recruitment strategy nature uses to evolve enzymes.155
6.3 Expression and Purification
A synthetic gene encoding for TmaPfuDAH7PS was designed and ordered
from GeneArt® Gene Synthesis service.i The construct was codon optim-
ised for E. coli, cloned into the Gateway® entry vector pDONR™ 221 and
sequence-verified prior to arrival. An expression clone was generated in an
untagged vector, pDEST14, using standard Gateway® technology and this
construct was transformed into E. coli One Shot® BL21 Star™ (DE3) cells.
The expression of TmaPfuDAH7PS in this cell line produced protein of the ap-
propriate molecular weight as observed by SDS-PAGE. However, the protein
predominantly appeared in the cell debris after lysis by sonication (Figure
6.3). The co-expression of different chaperones has been frequently used to
help alleviate expression stress and increase the solubility of recombinant
i The codon-optimised nucleotide gene sequence of TmaPfuDAH7PS is located in the
Appendix.
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Figure 6.3: SDS-PAGE analysis of protein expression of TmaPfuDAH7PS from E.
coli BL21(DE3) cells after lysis in the supernatant (lane 1) and cell debris (lane 2).
Figure 6.4: Role of molecular chaperones in protein folding and disaggregation.
The DnaK system (DnaK, DnaJ, GrpE) in combination with the chaperonins
(GroESL) may assist the folding intermediates to reach their native folded structure.
During aggregation the small heat shock proteins IbpAB (orange triangles) bind
the misfolded proteins and ClpB triggers the disaggregation process. Diagram
adapted from deMarco.159
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Figure 6.5: SDS-PAGE analysis of protein expression of TmaPfuDAH7PS from
E. coli Chaperone 3 (DE3) cells after lysis in the debris (lane 1) and supernatant
(lane 2).
proteins.159 Therefore, the vector containing TmaPfuDAH7PS was transformed
into E. coli BL21(DE3) pBB540/pBB542 (Chaperone 3) cells. These cells
contain a number of chaperones, dnsK, dnaJ, grpE, clpB and groESL, which
are thought to help improve protein solubility by allowing chaperone-assisted
folding (Figure 6.4).
The co-expression of TmaPfuDAH7PS with the E. coli chaperonins res-
ulted in soluble protein, as seen by SDS-PAGE analysis through protein of
the appropriate molecular weight in the supernatant fraction. SDS-PAGE
analysis of the supernatant and pellet fractions after cell lysis showed that
approximately fifty percent of the total protein expressed was present in the
soluble fraction (Figure 6.5), however this appeared to be a considerable
improvement from expression in the E. coli BL21(DE3) cells (Figure 6.3).
Therefore, purification of this enzyme continued. TmaPfuDAH7PS was puri-
fied using the same methods used for TmaDAH7PS, namely heat treatment
followed by HIC and SEC (Chapter 2, Section 2.3).
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6.4 Confirmation of Molecular Weight
The molecular mass of TmaPfuDAH7PS was 37068Da as determined by electro-
spray ionisation mass spectrometry. This value is identical to the molecular
weight calculated from the 333 amino acid ORF for TmaPfuDAH7PS.
6.5 Circular Dichroism Spectrophotometry
To assess protein folding of the chimeric protein, the secondary structure of
TmaPfuDAH7PS was investigated using circular dichroism (CD) spectrophoto-
metry. The spectrum recorded for TmaPfuDAH7PS (Figure 6.6) is similar to the
closely-related KDO8PS enzymes, which have a similar fold,48 and indicates
a secondary structure typical of a (β/α)8 tertiary structure.160 Furthermore,
comparison of the CD spectra of TmaPfuDAH7PS with that of TmaDAH7PS
suggests the chimeric protein is correctly folded.
Figure 6.6: Comparison of the CD spectra of TmaPfuDAH7PS (solid line) and
TmaDAH7PS (short dashes).
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Table 6.1: Comparison of kinetic parameters for TmaPfuDAH7PS, TmaDAH7PS
and PfuDAH7PS enzymes.
Enzyme KPEPm (µM) KE4Pm (µM) kcat (s−1) Temp. (℃) Reference
TmaPfuDAH7PS 46 ± 4 10 ± 1 2.41± 0.02 60 This study
PfuDAH7PS 120 ± 20 28 ± 4 1.5 ± 0.1 60 Schofield38
TmaDAH7PS 4.85± 0.04 13 ± 1 11.7 ± 0.2 60 This study
6.6 Kinetic Parameters
TmaPfuDAH7PS was found to be catalytically active, consistent with the
observation showing the protein is correctly folded. The values of the kinetic
parameters for freshly purified TmaPfuDAH7PS were determined in the same
manner as for wild-type TmaDAH7PS by following the loss of PEP absorbance,
spectrophotometrically, at 232 nm and 60℃. The apparent Km values for
E4P and PEP were 10 ± 1 µM and 46 ± 4µM, respectively, and kcat of 2.41 ±
0.02 s−1. These Km values are similar to those for both PfuDAH7PS and Tma-
DAH7PS (Table 6.1). The kcat is very close to that reported for PfuDAH7PS,
from which the catalytic barrel of TmaPfuDAH7PS is derived.38 Furthermore,
some variation of the kcat value for PfuDAH7PS has been previously noted
(Schofield, unpublished data).
6.7 Feedback Inhibition
Two aromatic amino acids were tested as potential feedback inhibitors of
TmaPfuDAH7PS, as described in Chapter 8, Section 8.6.4. Tyr and Phe at
increasing concentrations were tested for their effect on enzyme activity. Tyr,
and to a lesser extent Phe, were shown to have an inhibitory effect on the
enzyme (Figure 6.7). The inhibition by Tyr is much smaller for TmaPfuDAH7PS
than for wild-type TmaDAH7PS (Figure 6.7) and even at increased inhibitor
concentrations (up to 1mM), the enzyme may still not be maximally inhibited.
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(a)
Figure 6.7: Effect of Tyr and Phe on the activity of TmaPfuDAH7PS in response
to increasing concentrations of Tyr () and Phe (•) in comparison to the inhibition
of TmaDAH7PS by Tyr (N) and Phe (H). Triplicate assays were performed and
error bars represent the standard deviation.
6.8 Kinetic Parameters in the Presence of
Tyr
To determine if the presence of Tyr has the same effect on catalysis as for
TmaDAH7PS, kinetic parameters were determined for TmaPfuDAH7PS in the
presence of Tyr (500 µM). The apparent Km for PEP remained relatively
unchanged, whereas the enzyme showed a reduced affinity for E4P (KPEPm of
42 ± 2 µM, KE4Pm of 20 ± 2 µM) and slightly lower kcat (1.6 ± 0.1 s−1) when
compared to the parameters determined for TmaPfuDAH7PS in the absence of
Tyr (Table 6.1).
These results differ from the observed kinetic parameters for wild-type
TmaDAH7PS determined in the presence of Tyr. In the presence of Tyr
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(150µM), TmaDAH7PS displayed a reduced affinity for both substrates,
particularly for E4P, and a reduced kcat. TmaPfuDAH7PS required a higher
inhibitor concentration than wild-type TmaDAH7PS to affect catalysis and
this reflects the heightened sensitivity of TmaDAH7PS towards inhibitors
compared to TmaPfuDAH7PS.
6.9 Small Angle X-ray Scattering
SAXS was employed to determine if the conformational change on binding of
Tyr, seen in solution for TmaDAH7PS, also occurs for TmaPfuDAH7PS. Data
were collected in the presence and absence of Tyr. In the absence of Tyr, the
profile closely resembles the predicted profile for TmaDAH7PS (Figure 6.8a).
This confirms that the protein adopts the same tetrameric structure and the
same open conformation as seen for wild-type TmaDAH7PS. On treatment
with 1mM Tyr, the profile changed significantly, which is in line with the
changes observed for wild-type TmaDAH7PS (Figure 6.8b).
For the scattering profile of TmaPfuDAH7PS in the absence of Tyr, the
radius of gyration (Rg), as determined by Guinier analysis, was 34.2 ± 0.2Å,
and as calculated using the indirect Fourier transform method from the
pair distribution function (P(r)), 34.3 ± 0.1Å (Figure 6.9a and 6.9c). The
maximum dimension of the scattering particle (Dmax) was approximately
100Å, which is in close agreement with the Tyr-free open crystal structure of
wild-type TmaDAH7PS (PDB code 1RZM) when analysed with CRYSOL
(Dmax of approximately 106Å) with a χ2ν of 0.7.
In the presence of Tyr, the Rg determined from the Guinier analysis
(Figure 6.9b) and P(r) are similar (33.1 ± 0.1Å and 32.8 ± 0.03Å, respect-
ively) and the Dmax calculated from the P(r) was approximately 90Å (Figure
6.9d). Again, this is in close agreement with the CRYSOL analysis of the
closed Tyr-bound TmaDAH7PS structure (Dmax of approximately 95Å) with
a χ2ν of 1.4.
These data suggest that the engineered TmaPfuDAH7PS enzyme behaves
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(a)
(b)
Figure 6.8: SAXS measurements of TmaPfuDAH7PS in the absence and presence
of Tyr. Theoretical scattering coordinates were generated from crystallographic
coordinates from both the open Tyr-free TmaDAH7PS, PDB code 1RZM (—) and
Tyr-bound TmaDAH7PS structure PDB code 3PG9,(—) using CRYSOL. These
theoretical plots have been compared to the experimentally determined scattering of
TmaPfuDAH7PS (◦) in the (a) absence and (b) presence of Tyr. Reduced chi-squared
(χ2ν) for the fit to the calculated CRYSOL data for the open (PDB code 1RZM)
and closed conformation (PDB code 3PG9) values are for (a) 0.70 and 5.12 and (b)
7.53 and 1.40 respectively.
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(a) (b)
(c) (d)
Figure 6.9: For TmaPfuDAH7PS data collected in the (a) absence and (b) presence
of Tyr, Guinier plots were linear for s · Rg < 1.3. P(r) function calculated, using
GNOM,125 from TmaPfuDAH7PS SAXS data (c) without (d) with Tyr. Error bars
indicate uncertainty in P(r) propagated from the I (s) vs s profile.
similarly to TmaDAH7PS in the presence of Tyr and adopts a more compact,
globular structure. The SAXS and inhibition results for TmaPfuDAH7PS
suggest that the fusion of the regulatory ACT domain from TmaDAH7PS to
the catalytic barrel of PfuDAH7PS transfers the property of allosteric control
of catalytic function.
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(a) (b)
Figure 6.10: The best diffracting crystals of TmaPfuDAH7PS from (a) C3 and (b)
in-house crystal trials.
6.10 Crystallisation and Structure
6.10.1 Crystallisation Trials
Crystal trials were performed both in house and at the Collaborative Crys-
tallisation Centre (C3) operated by CSIRO. Initial screens were set up at
C3 using the sitting-drop vapour diffusion method at 281K or 293K, in the
presence of Tyr.
The best diffracting crystal grown at C3 grew from a reservoir con-
taining 0.2M sodium chloride, 0.1M Tris, pH 8 and 20% (w/v) PEG 6000
(Figure 6.10a). In house crystal trials were performed using the sitting-drop
vapour diffusion method and either JCSG+ or PACT Suite Crystal Screens,
supplemented with Tyr and MnSO4 and incubated at 293K. The screen
conditions that grew crystals were optimised by varying precipitant and salt
concentration using the hanging-drop diffusion method. The best diffracting
crystal resulting from in house trials (Figure 6.10b) grew from a reservoir
containing 0.2M CaCl, 0.1M sodium acetate, pH 4.6, 300µM MnSO4, 0.02%
(w/v) sodium azide and 1mM Tyr.
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6.10.2 Structure
Refinement of X-ray data collected from the crystal grown from the C3 screens
(Table 6.2) indicates that TmaPfuDAH7PS adopts a closed conformation in the
presence of Tyr (Figure 6.11). Electron density confirms the presence of Tyr
bound in the same location as in wild-type TmaDAH7PS. As the resolution
obtained for this structure is relatively low (3Å), higher resolution data are
being sought.
6.11 Discussion
The primary goal of protein engineering is to create a novel protein that
possesses some improved or novel property. The construction of hybrid
enzymes can be achieved by changing the amino acid sequence and can be
approached using a variety of different techniques, including the modification
of existing protein frameworks, random mutagenesis, or the less stochastic
approach of combining known properties in existing proteins.
Point mutations and/or exchanges of secondary elements have been
used to create chimeric or hybrid proteins with improved catalytic efficiency,
stability, protein folding,159 decreased susceptibility to proteases, exchanged
or broadened substrate specificity,161–167 regulated activity168,169 or altered
non-catalytic properties, such as thermostability.170
Although domain recruitment for the purpose of allosteric regulation
is apparent in nature, and a number of bifunctional enzymes have been
engineered by domain insertion,171 the exchange of functional domains to
engineer allosteric regulation has not been extensively explored.152 A protein
that couples two functions, such as an allosteric enzyme, or “molecular
switch”,172 couples effector signals (input) to enzyme activity (output) and has
potential for applications, such as biosensors,171,173–176 novel biomaterials,177
and modulators of gene transcription and cell signalling pathways.178–180
Despite this vast potential, the myriad of design strategies and engineering
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Table 6.2: Crystal parameters, data collection, and refinement statistics for
TmaPfuDAH7PS in complex with Tyr
TmaPfuDAH7PS
Data collection
Space group P212121
Cell dimensions
a, b, c (Å) 76.9, 130.9, 138.1
α, β, γ (°) 90.0, 90.0, 90.0
Resolution range (Å) 37.94–3.00 (3.08–3.00)a
Rmergeb 0.101 (0.581)
I/σ(I ) 7.0 (1.3)
Completeness (%) 95.5 (97.6)
Redundancy 3.0 (3.0)
Refinement
No. of reflections 80989
No. of unique reflections 27079
Rwork/Rfreeb 0.195/0.276
No. of atoms
Protein 9959
Ligand/ion 4
Water 23
B-factors (Å2)
Protein 61.57
Ligand/ion –
RMSD
Bond lengths (Å) 0.008
Bond angles (°) 1.228
aValues in parentheses are for the highest resolution shell.
bRmerge=
∑
h
∑
i |Ii(h)− 〈I(h)〉| /∑h∑ iIi(h) and is provided by SCALA.
r =∑ ‖Fobs|−|Fcal‖ /∑ |Fobs|, where Fobs and Fcal are the observed and calculated
structure-factor amplitudes, respectively for the working set (Rwork) and test set
(Rfree) of reflections and are provided by REFMAC5.
Refinement parameters which have not yet been determined are denoted with
dashes.
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(a)
(b)
Figure 6.11: Preliminary structure of TmaPfuDAH7PS tetramer looking (a) down
on and (b) side on to the tetramer with Tyr (shown as spheres with the carbon
atoms coloured cyan) modelled into the ligand-binding site.
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difficulties means there have been relatively few reported attempts to create
allosteric enzymes.179,181–185
In the Iβ subfamily of DAH7PS, domain recruitment for the purpose
of feedback regulation is clear from the inspection of sequence and structure.
However, within this subfamily there are both regulated and unregulated
forms of the enzyme. The creation of the chimeric protein TmaPfuDAH7PS,
in which the regulatory ACT domain from one enzyme was fused onto an
unregulated DAH7PS, resulted in a soluble, catalytically active and Tyr-
inhibited enzyme. However, the catalytic activity of TmaPfuDAH7PS is not
as sensitive to Tyr inhibition as wild-type TmaDAH7PS, the enzyme from
which TmaPfuDAH7PS is modelled.
The ability of two ACT domains to interact appears to be the most
important prerequisite for conferring allostery. It is easy to comprehend
how this mechanism of regulation has evolved as it does not require any
significant sequence or structural modifications to the core catalytic barrel.
Additional to the contacts found between interacting regulatory domains, a
number of contacts between the regulatory domain and catalytic barrel were
highlighted on analysis of ligand-induced domain closure of TmaDAH7PS,
specifically Arg277, Pro303, Glu304 and Asp309. Although these residues are
not generally conserved within the barrel region of undecorated Iβ DAH7PS
enzymes, all of these residues are conserved between PfuDAH7PS and Tma-
DAH7PS, and are therefore present in TmaPfuDAH7PS. Thus, it could be
considered that transfer of allosteric regulation through fusion of a known
regulatory element may have been assisted due to these critical contacts
between the domains being present. The importance of these interactions to
allostery is unknown. It appears that the ability and flexibility required for
domain closure is a property of the domain itself but there are features of the
catalytic barrel that could enhance this process.
The results obtained for TmaPfuDAH7PS support the hypothesis of do-
main recruitment for regulation and the associated implications of how the
ACT domain confers allostery. Taken together with the results observed for
TmaPfuDAH7PS, another study strengthens the potential for the transfer of
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allosteric behaviour by domain recruitment. Random domain insertion of E.
coli MBP into the penicillin-hydrolysing enzyme TEM-1 β-lactamase (BLA)
was attempted in order to create an allosteric enzyme.172 MBP was used to
modulate the enzyme activity of BLA and this protein was chosen because of
the large conformation change that occurs on ligand binding (a 35 ° closure
and a −3.5 ° twist),186 and because the conformational change observed for
MBP has been exploited for the creation of molecular sensors.175,176 Inter-
estingly, one of the allosteric enzymes identified from the random library
was essentially an end-to-end fusion of the two genes, MBP-BLA. This was
an unexpected result as previous studies had not reported the switch be-
haviour of this construct.182 However, an internal fusion produced a more
ligand-sensitive enzyme and was deemed more successful.172
Unlike the MBP-BLA fusion protein in which only kcat is affected by
the presence of inhibitor (maltose),172 TmaPfuDAH7PS behaves more like
other allosteric enzymes where regulation is achieved through effects on Km
(binding) alone. SAXS and crystal data suggest the regulation mechanism
of TmaPfuDAH7PS mimics that of TmaDAH7PS, where two ACT domains
associate and bind Tyr between them, which physically gates substrate entry
to the active site. Although a recurring motif, the ACT domain displays a
multitude of variations in tertiary and quaternary architecture. Similarly,
diversity of ligand-binding interactions is also noted in the small number of
ligand-bound ACT domain structures solved. Despite these differences, it is
obvious that the physical association between the ACT domains is a feature
of their function.130
As more allosterically regulated enzymes are structurally characterised
with ligands bound, other recurring domains similar to the ACT domain
may be discovered, their mechanism for conferring allostery will be revealed
and importance for regulation realised. Perhaps as more structure-function
relationships are uncovered, other enzymes will reveal the importance of do-
main recruitment and large conformational changes associated with allosteric
control.

121
Chapter 7
Summary of Thesis and Future
Directions
This thesis describes functional and structural investigations of the type Iβ
DAH7PS from T. maritima. The crystal structure of Tyr-bound TmaDAH7PS
reported in this thesis is the first reported structure of an inhibitor-bound
type Iβ DAH7PS enzyme.
The functional studies of TmaDAH7PS presented here expand upon
initial examinations of this enzyme reported by others.64 Kinetic parameters
and inhibition data were broadly in line with results already published,
confirming that TmaDAH7PS is a metal-dependent enzyme, which is strongly
inhibited by Tyr and to a lesser extent by Phe.
7.1 The N-terminal βαββαβ Domain is
Required for Allosteric Regulation
Truncation of the putative regulatory N-terminal domain, or ACT domain,
of TmaDAH7PS resulted in a catalytically active enzyme. However, the
truncated enzyme was insensitive to the inhibitors Tyr and Phe. Interestingly,
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truncTmaDAH7PS was more catalytically active than wild-type TmaDAH7PS,
suggesting the enzyme pays a catalytic penalty to accommodate the regulatory
function. The crystal structure of truncTmaDAH7PS showed the overall
structure of the enzyme was not disturbed by removing the ACT domain.
However, in contrast to the wild-type protein, which is tetrameric, this enzyme
is dimeric in the crystal form. This change in quaternary structure was further
investigated by SAXS where truncTmaDAH7PS was found to be tetrameric,
suggesting that the regulatory domain may stabilise quaternary structure.
Further investigations into the quaternary structure of the enzyme and the
importance of the regulatory domain for its stabilisation are required.
7.2 Mechanism of Allosteric Regulation
Shown to Involve a Large
Conformational Change
After establishing that the N-terminal domain of TmaDAH7PS is essential
for allosteric regulation, the crystal structure of TmaDAH7PS in complex
with Tyr was determined. Tyr was found to bind at the interface between
two regulatory domains, formed from diagonally located monomers of the
tetramer, revealing a major reorganisation of the regulatory domain with
respect to the barrel relative to the unliganded enzyme. This significant
conformational change observed in the crystal structure was corroborated
by SAXS measurements collected in the presence and absence of Tyr. The
closed conformation adopted by the protein on Tyr binding impedes substrate
entry into the neighbouring barrel, revealing an unusual Tyr-mediated gating
mechanism for regulation of this enzyme.
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7.3 Hydrogen Bonding to Ser31 is
Important for Inhibition by Tyr
Investigations into the important interactions between the inhibitor Tyr and
enzyme showed that removal of the side chain of Ser31 substantially com-
promised inhibition by Tyr, and to a lesser extent by Phe. This finding
suggests that the hydroxyl side chain of Ser31 is important for both the
preferential inhibition by Tyr over Phe, and the inhibitory mechanism. Curi-
ously, mutation of His29 (the hydrogen-bonding partner of Ser31) to Ala
decreased sensitivity towards Tyr but increased inhibition by Phe. Exchange
of the position of Ser31 and His29 showed that the relative positioning of
these residues plays an important role in the inhibition of the enzyme. SAXS
analysis showed that although the mutated enzymes were less sensitive to the
inhibitory ligands, they still exhibited the conformational change observed
for the wild-type enzyme in the presence of inhibitors. Residues that inter-
act with the carboxylate or amino functionality of the bound-Tyr ligand or
those that provide hydrogen-bonding contacts between two opposing ACT
domains, namely Glu35, Arg36 and Arg46, could be targeted for mutation
and investigated for their effect on Tyr binding.
7.4 Allosteric Regulation Can Be
Transferred
Fusion of the ACT domain of TmaDAH7PS onto the undecorated, unregulated
PfuDAH7PS scaffold resulted in a catalytically active enzyme. Unsurprisingly,
the enzyme had lower activity than its wild-type counterpart PfuDAH7PS.
However, the chimeric enzyme was inhibited by both Tyr and to a lesser extent,
Phe. The conformational change observed by SAXS analysis for wild-type
TmaDAH7PS was also observed for the fusion enzyme. This suggests that
transfer of the property of allosteric regulation by fusion of an ACT domain is
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indeed possible in line with the physical gating mechanism being principally
a function of the regulatory domain. Although allostery was shown to be
transferable, the inhibition was not as effective as for TmaDAH7PS, suggesting
that features of the barrel-regulatory domain pairing require optimisation.
This suggests that successful transfer is dependent on the presence of other
factors that influence the transmission of the regulatory signal.
7.5 Future Experiments
Does Phe bind to TmaDAH7PS in the same site as
Tyr?
Assuming Phe binds in the same position as Tyr, determination of the crystal
structure of TmaDAH7PS in the presence of Phe may help explain why this
inhibitor is not as effective as Tyr. It may also help explain the interactions
that are important for Phe binding, and help elucidate what defines the
specificity of the enzyme for Tyr over Phe.
What influence does the ACT domain have on
quaternary structure?
Further investigations into the quaternary structure of TmaDAH7PS in solu-
tion are required, particularly to assess the different stabilities of the dimeric
and tetrameric forms of the enzyme. Analytical ultracentrifugation (AUC)
analysis of truncTmaDAH7PS may show whether a dimeric and/or tetrameric
structure is adopted and whether quaternary structure is concentration-
dependent. Futhermore, the tetramer interface of TmaDAH7PS could be
disrupted by mutation to mimic the dimeric structure observed in the crystal
form of truncTmaDAH7PS, and the mutated enzyme tested for sensitivity
towards Tyr. This may uncover the interplay between quaternary structure
and regulation.
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Is the ACT domain transferable to other DAH7PS
enzymes?
Fusion of the ACT domain onto another unregulated DAH7PS enzyme may
show if allosteric regulation is generally a transferable property. Targets should
include fusion to barrels where some of the interactions between the barrel and
regulatory domain are unlikely to be formed. Although sequence analysis may
assist in the identification of other unregulated DAH7PS enzymes, the lack
of structural information and functional characterisation available somewhat
limits the choice for a barrel scaffold to ApeDAH7PS. However, ApeDAH7PS
shares every barrel contact to the ACT domain with TmaDAH7PS. Therefore,
selecting a barrel template that shows variation in these residues may be more
informative as to whether these contacts are essential for allosteric inhibition.
In addition, mutations designed to disrupt the interactions between the ACT
domain and barrel may also provide similar insights.
To assess the ability of the ACT domain to form a dimer without
assistance from barrel residues, the ACT domain could be expressed and
purified in the absence and presence of Tyr.
Concluding Remarks
Regulation is incredibly important for understanding enzymatic function
and there are not many reported examples with all the information required
to understand this phenomenon at a molecular level. TmaDAH7PS has
illustrated a remarkable regulatory mechanism, and moreover, has been shown
to have a mechanism that is readily transferable, allowing the evolution of
complex regulatory systems to be unravelled.
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Chapter 8
Experimental Procedures
8.1 General Methods
8.1.1 Amino Acid Sequence Alignments
Multiple amino acid sequence alignments were generated using ClustalW
(http://www.ebi.ac.uk/clustalw/) or TCoffee (http://tcoffee.crg.cat/apps/
tcoffee).
8.1.2 Protein Structure Figures
All protein structure figures were created using The PyMOL Molecular
Graphics System (version 1.5, Schrödinger LLC).187
8.1.3 Purified Water
All water was purified by passage through a Millipore Milli-Q water system.
This is referred to as Milli-Q water throughout this thesis. All Milli-Q water
used for molecular biology was autoclaved prior to use.
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8.1.4 pH Measurement
The pH of all solutions was measured at room temperature using a Denver
UB-10 Ultrabasic pH meter with either a standard or micro-probe. The pH
was adjusted using 1M or 10M HCl (or glacial acetic acid when required) or
1M or 10M NaOH.
8.1.5 Removal of Metal Ions from Solution
Metal ions were removed from solution by treatment with Chelex® 100 resin
(Bio-Rad). The resin was added and left to stir overnight before the resin was
removed by filtration (0.2 µm). The pH of all solutions was re-adjusted after
Chelex® treatment.
8.1.6 Agarose Gel Electrophoresis
DNA fragments were separated on an agarose gel, prepared using a solution
of 1% (w/v) LE agarose (Seakem) in 50× Tris base-acetic acid-EDTA (TAE)
buffer (2M Tris-HCl, 1M glacial acetic acid, 100mM EDTA) heated in a
microwave oven until dissolved and left to equilibrate at 60℃ before addition
of SYBR® Safe DNA Gel Stain (Invitrogen). Samples were combined with
6× loading buffer (60mM Tris-HCl, 60mM EDTA, 0.02% (w/v) orange G,
0.05% (w/v) xylene cyanol FF, 60% glycerol). Hand-cast gels were run in
1× TAE buffer using a Mini-sub cell GT (Bio-Rad) at 85V until the dye
front had migrated far enough to allow sufficient separation of the samples.
Gels were visualised under UV (302 nm) and images were captured using a
Molecular Imager® Gel Doc™ XR (Bio-Rad).
Alternatively, DNA samples were loaded on an E-Gel® 1.2% precast
agarose gel (Invitrogen) in a buffer-free system and run for 27min. Separation
could be monitored in real-time using the E-Gel® iBase™ Power System and
E-Gel® Safe Imager™ Transilluminator at 480 nm.
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For size comparison DNA fragments were run alongside a 1 kB Plus
DNA ladder (Invitrogen).
8.1.7 LR Recombination Reaction
Sequenced plasmids were used to perform the Gateway® LR recombination
reaction, a reaction that facilitates transfer of a Gateway® entry clone to a
destination or expression vector. The LR Recombination Reaction consisted
of approximately 100 ng of sequenced plasmid, approximately 150 ng of the
appropriate destination vector and Tris-EDTA (TE) Buffer, pH 8 (10mM
Tris-HCl, pH 8.0, 1mM EDTA) made up to a final volume of 8 µL. LR
Clonase™ II enzyme mix (Invitrogen) was thawed on ice and gently mixed.
2 µL of the enzyme mix was then added, and the reaction mixture incubated
at 25℃ for 1 h. The reaction was terminated by the addition of 1 µg of
Proteinase K solution. The reaction mixture was then further incubated for
10min at 37℃.
8.1.8 Transformation of LR Recombination Reaction
The LR Recombination Reaction was used to transform competent E. coli
One Shot® TOP10 Chemically Competent Cells (Invitrogen). A 50µL aliquot
of competent cells was defrosted and incubated on ice for 30min with 1µL
of the reaction mixture. The cells were then heat-shocked for 30 s at 42℃
and immediately transferred to ice before 450µL of room temperature super
optimal broth (SOC) was added. The cells were incubated at 37℃ for 1 h
before being spread on pre-warmed LB-Amp plates and left to grow overnight
at 37℃.
8.1.9 Transformation
Chemically competent cells (50 µL) were thawed on ice before the addition
of 2µL of either purified PCR product of extracted plasmid. The mixture
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was left on ice for a further 30min before heat-shocked at 42℃ for 30 s to
45 s. The cells were then replaced on ice for 2min before the addition of
200 µL to 250 µL of SOC medium (2% (w/v) tryptone, 0.5% (w/v) yeast
extract, 10mM NaCl, 2.5mM KCl, 10mM MgSO4 and 20mM glucose, filter
sterilised) and outgrown at 37℃ for 1 h with shaking (200 rpm). An aliquot
of transformed cells (75 µL to 200 µL) was spread directly onto a pre-warmed
lysogeny broth (LB)-agar plate containing the appropriate antibiotics and
left to grow overnight, inverted, at 37℃.
8.1.10 Chemically Competent Cells
All chemically competent cells used in this thesis were commercially prepared
and supplied (Invitrogen or Novagen).
8.1.11 Plasmid Extraction and Isolation
Plasmids were extracted from 5mL cultures, containing the appropriate anti-
biotic, and grown overnight at 37℃ using a High Pure Plasmid Isolation Kit
(Roche). The concentration of purified plasmid was measured by absorption
at 260 nm using a Nanodrop-1 000 spectrophotometer.
8.1.12 DNA Sequencing
DNA sequencing services were provided by Canterbury Sequencing and Gen-
otyping based at the University of Canterbury. Sequencing was carried out
using an Applied Biosystems 3130xl Genetic Analyzer and BigDye Terminator
v3.1 (Applied Biosystems) used for the sequencing chemistry. Approximately
250 ng of purified double-stranded plasmid and 3.2µM of primer were supplied
for each sample.
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8.1.13 Antibiotic Stocks
Stock solutions at 100mgmL−1 of Amp and kanamycin (Kan), and 10mgmL−1
of spectinomycin (Spec) were made up in Milli-Q water. 30mgmL−1
chloramphenicol (Cam) was made up in analytical reagent (AR) ethanol.
All solutions were filter sterilised (0.2 µm) into sterile micro-centrifuge tubes
and stored at −80℃.
8.1.14 Glycerol Stocks
All strains of E. coli were grown overnight at 37℃, of which an aliquot was
taken. Glycerol was then added to give a final concentration of 20% (v/v), the
culture was then thoroughly combined in a sterilised 1.7mL micro-centrifuge
tube, snap frozen in liquid nitrogen and stored at −80℃.
8.1.15 Media
All E. coli cultures were grown in LB (Lennox L) at 20 gL−1 (Invitrogen)
made up with Milli-Q water and were sterilised by autoclaving at 121℃ at
15 psi for 20min. Agar was added to the media used for agar plates (25 g L−1)
(Invitrogen) before sterilisation. Prior to use, the LB-agar solution was heated
in a microwave oven until boiling, then left in a 60℃ oven for at least 1 h.
The appropriate antibiotics were added immediately prior to pouring. SOC
media was added to freshly transformed E. coli cells. Solutions consisted of
2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10mM NaCl, 2.5mM KCl,
10mM MgCl2 and 20mM glucose. All components were added to Milli-Q
water except for 10mM MgCl2 and 20mM glucose, which were filter sterilised
and added immediately prior to use.
8.1.16 Centrifugation
All centrifugation was carried out using the following:
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• Sorvall Evolution RC (Thermo Scientific)
• Heraeus Multifuge 1 S-R (Thermo Scientific)
• Heraeus Fresco 17 (Thermo Scientific)
• Minispin® Centrifuge (Eppendorf)
8.1.17 Growth of E. coli Cells
All 1 L cultures of cells were grown from a 50mL overnight preculture of LB,
inoculated from a glycerol stock scraping and containing the appropriate an-
tibiotic. Cultures were grown in baffled flasks at 37℃ with shaking (180 rpm)
until mid-logarithmic phase (OD600 of 0.4AU to 0.8AU).
8.1.18 Induction of Protein Expression
Expression of genes inserted in pT7-7 and pProEX-HT vectors are under
control of a lac promoter and are thereby induced by lactose. IPTG is a
synthetic analogue of lactose that triggers transcription of the lac operon,
thereby protein expression, but is not metabolised by the cell as lactose
is, which ensures a constant concentration of inductant is maintained. To
induce protein expression, IPTG (Roche) was added to the cultures to a final
concentration of 1mM.
8.1.19 Harvesting of Cells
Cells were harvested approximately four hours after induction by centrifuga-
tion (14 000 g, 4℃, 20min or 12 000 g, 4℃, 15min). Cell pellets were stored
at −80℃ until lysis.
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8.1.20 Cell Lysis
Cell lysis was performed in one of two ways: Lysis by sonication was performed
using an Omni-Ruptor 4000 Ultrasonic Homogenizer (Omni International)
with either a titanium 38 inch or
5
32 inch probe. Typically, cell pellets were
resuspended in 20mL chilled lysis buffer, sonicated in a beaker surrounded
with ice with 4–6 multiples of 5min at 80% and 30% to 40% pulsation.
The alternative method for lysis was the more gentle chemical detergent
lysis using BugBuster® 10× Protein Extraction Reagent (Novagen). Cell
pellets were resuspended in lysis buffer with a volume of BugBuster® equivalent
to 1/20th of the original bacterial culture volume pelleted and Nuclease
(Novagen) (an engineered promiscuous endonuclease) was added per mL of
BugBuster®. The cell suspension was shaken at 37℃ for at least 20min.
Cell debris was removed by centrifugation (12 000 g, 4℃, 30min or
24,000 g, 4℃, 30min or 30 000 g, 4℃, 15min).
The lysis buffer for all proteins consisted of 10mM 1,3-(tris(hydroxy-
methyl)-methylamino)propane (BTP), pH 7.3, 200mM KCl, 200 µM PEP
and 1mM EDTA.
8.1.21 Fast Protein Liquid Chromatography
Fast protein liquid chromatography (FPLC) was carried out using a Bio-
Rad Biologic Protein Chromatography system or a ÄKTApurifier™ 10 (GE
Healthcare) at either 4℃ or room temperature. All buffers and solvents
were filtered prior to use using a 0.2 µm filter (Millipore). Protein samples
were also filtered (2 µm) before being loaded onto a 50mL Superloop™ (GE
Healthcare). The eluant was fractionated in 2mL fractions and collected in
96-well plates.
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8.1.22 Hydrophobic-Interaction Chromatography
The supernatant fraction after heat treatment was pooled, ammonium sulfate
added to a final concentration of 1M, and loaded onto a SOURCE™ 15Phe®
(GE Healthcare) column (8mL), equilibrated in 10mM BTP, pH 7.5, 1mM
EDTA and 1M (NH4)2SO4 (Buffer A) at room temperature. The unbound
protein was removed with four column volumes of Buffer A and the bound
protein was eluted with five column volumes of Buffer B (10mM BTP, pH
7.5, 1mM EDTA) at a flow rate of 2mLmin−1. Fractions that eluted with
Buffer B and those that showed UV absorbance at 280 nm were analysed by
SDS-PAGE. Those fractions containing the protein of interest were pooled
and concentrated using a 20mL 10 kDa molecular weight cut-off (MWCO)
device (Sartorius Stedim Biotech).
8.1.23 Size-Exclusion Chromatography
SEC using a Superdex S200 26/60 (GE Healthcare) or Superdex S200 HR
10/300 column (GE Healthcare) was used as a final purification step for all
proteins discussed in this thesis. This step was used to separate proteins from
any contaminating DNA and to exchange proteins into more suitable buffers
for crystallisation trials.
Protein was injected onto the column under isocratic conditions with
a flow of 0.2mLmin−1 to 2mLmin−1. The SEC buffer used for all proteins
consisted of BTP (10mM, pH 7.5) supplemented with KCl (100mM), PEP
(200µM) and EDTA (1mM).
All buffers were made up using Milli-Q water. Fractions that gave an
absorbance at 214 nm and/or 280 nm were analysed by SDS-PAGE.
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8.1.24 Cleavage of N-terminal MBP and His6-tag by
rTEV
Fractions containing DAH7PS, as determined by SDS-PAGE were pooled,
washed with loading buffer using a desalting column to remove any maltose
and dithiothreitol (DTT) (1mM) added. The protein was then incubated for
up to 24 h at room temperature (approximately 22℃) with recombinant TEV
(rTEV) protease (1 OD280 of TEV protease per 10 OD280 protein) (rTEV
kindly donated by Dr Andrew Muscroft-Taylor). The completeness of cleavage
was assessed by SDS-PAGE. The rTEV was successfully removed in the next
step of purification by heat treatment or reapplication to HisTrap™ column
(GE Healthcare).
8.1.25 Polyacrylamide Gel Electrophoresis
SDS-PAGE was performed using the method of Laemmli188 with either a
hand-cast gel made up of a 4% stacking gel and 12% (w/v) separating gel,
run using a Mini Protean II cell (Bio-Rad) or a NuPAGE® Novex 10% Bis Tris
1.0mM precast protein gel (Invitrogen) run in a XCell SureLock® Mini-Cell
(Invitrogen). Samples were not boiled before application to gel. Novex®
Sharp Prestained Protein Standards (Invitrogen) or Low Range SDS-PAGE
molecular weight standards (Bio-Rad) were used. A constant voltage of 200V
was applied across the electrodes until the dye front reached the bottom of
the gel. After electrophoresis, gels were stained for protein using Coomassie
Brilliant Blue R250 in 50% (v/v) methanol, 10% (v/v) acetic acid in water
for approximately 30min. To remove the excess dye, the gel was then detained
for 30min in a solution containing 40% (v/v) methanol and 10% (v/v) acetic
acid.
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8.1.26 Buffer Exchange and Concentration of Protein
Proteins were concentrated during and after purification using either a 20mL
or 70mL 10 000Da MWCO device (Sartorius Stedim Biotech). All filtration
devices were washed before use with 2–3 equivalent volumes of Milli-Q water.
Protein solutions were buffer-exchanged by dilution with the desired buffer
and repeatedly concentrated.
8.1.27 Determination of Protein Concentration
Protein concentration was determined in one of two ways: Firstly, by the
method of Bradford, 1976,189 using bovine serum albumin (BSA) as a standard.
Standards were made from a 1mgmL−1 stock BSA solution. The assays were
performed by thoroughly mixing 20µL of protein or standard solution with
1mL of QuickStart Bradford Dye Reagent (Bio-Rad) and the absorbance at
595 nm used to calculate concentration using Cary UV software.
Alternatively, the protein concentration was measured by UV absorbance
at 280 nm using a Nanodrop ND-1 000 spectrophotometer (Thermo Scientific)
and 2µL sample of purified protein. The extinction coefficient value for
each protein was determined from the amino acid sequence using ExPASy-
ProtParam tool (http://web.expasy.org/protparam/). From this, absorbance
was converted to concentration using the Beer-Lambert Law. Triplicate
measurements were made and averaged.
8.1.28 Storage of Enzymes
Before storage, all purified enzymes were exchanged into buffers containing
no EDTA before being split into aliquots no larger than 200µL, snap frozen
in liquid nitrogen and stored at −80℃.
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8.1.29 Measurement of Molecular Weight
The masses of purified proteins were measured by electrospray ionisation using
either a Micromass LCT Classic (Waters) or Bruker maXis™ 3G (Bruker
Daltonics). Proteins were diluted from stored concentrations to 1mgmL−1
with Milli-Q water.
8.1.30 Standard Enzyme Assays and Kinetic
Measurements
The assay system used for DAH7PS was based on the assay used by Schoner
and Herrmann,28 as modified by Schofield et al.38 for use at 60℃. The
consumption of PEP was monitored at 232 nm ( of 2.6 × 103M−1 cm−1
at 60℃ or  of 2.8 × 103M−1 cm−1 at 25℃) using a Varian Cary 100 UV
Visible Spectrophotometer. Measurements were made using either 1 cm or
1mm path length quartz cuvettes. Standard reaction mixtures contained
PEP (approximately 150µM), E4P (approximately 200µM) and MnSO4
(approximately 100 µM) in BTP buffer (50mM, pH 7.3) and the enzyme to
make a total volume of either 1mL or 250µL. The BTP buffer was treated
with Chelex before use. PEP and E4P solutions were made up in the BTP
buffer solution. MnSO4 and amino acid solutions were made up in Milli-Q
water that had been treated with Chelex. Assays were performed at either
25℃ or 60℃.
Assays Performed at 60℃
Reaction mixtures containing BTP buffer, MnSO4 and PEP were incubated
for seven minutes at 60℃ before the addition of enzyme. The reaction mixture
was further incubated for two minutes before the reaction was initiated by
addition of E4P. Duplicate or triplicate readings of all measurements were
recorded and averaged.
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Assays Performed at 25℃
Reaction mixtures containing BTP buffer, MnSO4 and PEP and E4P were
incubated at 25℃ before the reaction was initiated by addition of enzyme.
Duplicate or triplicate readings of all measurements were recorded and aver-
aged. Initial rates of reaction were determined by a least squares fit of the
initial rate data. One unit (1U) of enzyme activity is defined as the loss
of 1 µmol of PEP per minute at 60℃ or 25℃. Specific activity is defined
as the loss of 1µmol of PEP per minute at 60℃ or 25℃ per mg of protein
(Umg−1). Km and kcat values were determined by fitting the data to the
Michaelis-Menten equation using Grafit (Erithacus).
8.1.31 Determination of Substrate Concentration
The concentration of PEP and E4P was determined using the standard
assay system. For example, for the concentration of E4P, a reaction mixture
consisting of approximately 150µM PEP, 100µMMnSO4, and enzyme is made
up before being initiated with the addition of 5µL of E4P stock solution (of
unknown concentration) to give a final concentration of 1mL. The reaction is
allowed to go to completion and the difference in absorbance before initiation
with E4P and the absorbance at completion of the reaction is measured. To
convert absorbance into concentration the Beer-Lambert Law is applied (A
=  c l, where l = 1 cm and  of 2.8 × 103M−1 cm−1 at 25℃ or  of 2.6 ×
103M−1 cm−1 at 60℃).
8.1.32 Crystallisation Trials
Screening for crystallisation conditions using sitting-drop vapour diffusion
in 96-well plates (Hampton Research) at 293K were performed by mixing
15µL of protein solution with 15 µL of well solution. Initial screens were
performed at the Collaborative Crystallisation Centre using the JCSG-plus
and PACT-screens (Qiagen). The concentration for protein solutions used
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for crystallisation trials were either 10mgmL−1 (TmaDAH7PS) or 5mgmL−1
(truncTmaDAH7PS).
Further manual screening was performed using both hanging-drop and
sitting-drop vapour diffusion in 96- or 24-well plates (1 µL + 1µL drops and
40 µL or 500 µL, respectively of appropriate well solution). Crystal trays
were set up at room temperature and then transferred to 20℃. Crystal trays
and pipette tips were flushed with nitrogen, to remove any contaminating
particles.
8.1.33 X-ray Data Collection
For X-ray data collection, crystals were transferred to reservoir solution
containing 20% (v/v) glycerol and flash-frozen in liquid nitrogen. Diffraction
data were collected at the Australian Synchrotron using the MX2 beamline
with a ADSC Quantum 315r detector (Area Detector Systems Corporation)
at a temperature of 110K. Data were collected by Dr Renwick Dobson.
8.1.34 Phasing and Model Refinement
Diffraction data were processed using MOSFLM134 and SCALA.135 Initial
phase estimates were calculated by molecular replacement using PHASER.190
The Rfree set (5%) was chosen from thin shells. Structural refinement was
performed using REFMAC5191 or PHENIX,192 with iterative model building
using COOT.193 NCS was included in the initial rounds of refinement and
waters were gradually added in the later rounds. TLS refinement was included
in the later rounds of refinement, with groups chosen using the TLSMD
server.194 Structures were validated using the MolProbity server.195
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8.1.35 Feedback Inhibition Studies
Solutions of either Phe (20mM), Tyr (20mM) or Trp (20mM) made up in
Chelex®-treated water were added to standard assay reaction mixtures to
give a total reaction volume of either 250µL or 1mL. Assays were initiated
by addition of E4P. All reactions were performed in duplicate or triplicate.
8.1.36 Small Angle X-ray Scattering Measurements
Measurements were performed at the Australian Synchrotron SAXS/WAXS
beamline equipped with a Pilatus detector (1M, 170mm × 170mm, effective
pixel size, 172 × 172µm). The wavelength of the X-rays was 1.0332Å.
The sample-detector distance was 1600mm, which provided an s range of
0.0126–0.6015Å−1 (where s is the magnitude of the scattering vector, which
is related to the scattering angle (2 θ) and the wavelength (λ) as follows: s
= (4pi/λ)sinθ). Scattering data were collected from enzymes (approximately
10mgmL−1) following elution from a size exclusion chromatography column
(Superdex 200 5/150), pre-equilibrated (10mM BTP pH 7.5, 100mM KCl,
200µM PEP) with or without amino acid (500 µM or 1mM).
Data were collected from a 1.5mm glass capillary at 27℃ at 2 s intervals.
Scattering from glucose isomerase (10mgmL−1) were collected for calibration.
Two-dimensional intensity plots from the peak of the size-exclusion chromato-
graphy run were radially averaged, normalised to sample transmission and
background subtracted.
8.1.37 Small Angle X-ray Scattering Data Analysis
Scattered intensity (I ) was plotted versus s. Extrapolation of the DAH7PS
I (s) profiles to zero angle (I (0 )) and comparison with that of glucose isomerase
standards indicated molecular mass. All samples were checked for an increase
in intensity at low s (indicative of aggregation). Guinier plots were linear for s
· Rg < 1.3. 1D profiles were background subtracted and Guinier fits were made
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using PRIMUS. Indirect Fourier transform was performed using GNOM125 to
yield the function P(r), which gives both the relative probabilities of distances
between scattering centers and the maximum dimension of the scattering
particle (Dmax).
Theoretical scattering curves were generated from atomic coordinates
and compared with experimental scattering curves using CRYSOL.196 OLI-
GOMER,197 which fits an experimental scattering curve from a multicom-
ponent mixture of protein structures, was used to find the volume fractions
of each component in the mixture. To assess and compare quality of the fits
in CRYSOL or OLIGOMER, χ2ν or χ2 values for the fits were compared, as
outlined in Mills et al.198
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8.2 Methods for Chapter Two
8.2.1 Amplification of the TmaDAH7PS Gene by
PCR
The cloning of the gene for TmaDAH7PS into the pT7-7 expression vector
was performed by Dr Mark Patchett prior to the start of this project. The
DNA encoding the ORF of TmaDAH7PS was amplified from T. maritima
MSB8 (DSM 3109) purified genomic DNA using primers designed specifically
to introduce NdeI and BglII recognition sites. The resulting 1036 bp PCR
product was ligated into pT7-7 previously digested with NdeI and BamHI,
and transformed into E. coli BL21 Rosetta cells (Novagen).
8.2.2 Kinetic Parameters
The assays performed to determine the kinetic parameters for wild-type Tma-
DAH7PS included 100µM MnSO4, 2µL 1.75mgmL−1 enzyme in 50mM BTP
pH 7.3 buffer. To determine KE4Pm , the PEP concentration was fixed at 82 µM
while the E4P concentration was varied (4 µM to 160 µM). For determination
of KE4Pm , E4P concentration was fixed at 161 µM while the PEP concentration
was varied (3 µM to 82 µM).
To determine the kinetic parameters in the presence of Tyr, the same
amount of enzyme was used, however 150µM Tyr was added to each assay
at the beginning of the incubation period. KE4Pm in the presence of Tyr was
determined by fixing the concentration of PEP at 125 µM while the E4P
concentration was varied (31 µM to 310 µM). For determination of the KPEPm ,
E4P concentration was fixed at 160 µM while the PEP concentration was
varied (11 µM to 165 µM).
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8.2.3 Activity in Presence of Inhibitors
To determine the loss of activity in the presence of Tyr or Phe, reaction
mixtures containing 145µM PEP, 10mM MnSO4 in 50mM BTP pH 7.3
buffer, 0 µM to 300 µM Tyr or Phe were incubated at 60℃ for seven minutes
before the addition of 2 µL of 1mgmL−1 enzyme. This mixture was incubated
for a further two minutes before being initiated with 180 µM to 195 µM E4P to
a final volume of 1mL. Initial rates were compared to those of standard assay
conditions to determine loss of activity. Triplicate assays were performed.
8.2.4 Metal Activation
The metal activation profile of wild-type TmaDAH7PS was determined using
standard assays with 124 µM PEP and 161µM E4P in 50mM BTP contain-
ing 10 µM EDTA, pH 7.3 at 60℃ and 100 µM of CoCl2, CdCl2, ZnCl2 or
MnSO4 made up in Chelex®-treated and filtered Milli-Q water. The enzyme
(2µL, 1.75mgmL−1) was incubated with the metal ion for two minutes prior
to activation with E4P, to a final volume of 1mL. Duplicate assays were
performed.
8.2.5 Response to Allosteric Effectors
Solutions of either Phe (20mM), Tyr (20mM) or Trp (20mM) made in water
were added to standard assay reaction mixtures containing PEP (145.8 µM)
and MnSO4 (100µM) in BTP buffer (50mM, pH 7.3) to give a final aromatic
amino acid concentration of 300µM. The reaction mixture was incubated for
seven minutes at 60℃ before the addition of enzyme (2µL, 2.12mgmL−1),
further incubation for 2 minutes and initiation with E4P (33µM). Duplicate
assays were performed.
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8.2.6 Differential Scanning Calorimetry
DSC analysis was carried out on a Nano II DSC (TA Instruments). Protein
solutions were dialysed against buffer containing 10mM BTP, pH 7.5, 100mM
KCl, 200µM PEP and 0.5mM tris(2-carboxyethyl)phosphine (TCEP) and
the concentration of protein adjusted to 1mgmL−1. The reference cell was
filled with the final dialysis buffer. For sample analysis in the presence of Tyr,
Tyr was added directly to both the enzyme and buffer to a final concentration
of 1mM. Samples were degassed before measurement and scanned from 20 ◦C
to 130 ◦C at a rate of 1℃min−1 under 3 atm of pressure.
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8.3 Methods for Chapter Three
8.3.1 Amplification of truncTmaDAH7PS Open
Reading Frame
The DNA corresponding to the ORF of truncTmaDAH7PS was amplified
from wild-type plasmid using Phusion High Fidelity® DNA polymerase (New
England Biolabs). Primers used for amplification were as follows:
truncTmaDAH7PS
For: 5’ CACCCTCGTTTCTCGTGAGTTCCATCC
Rev: 5’ TCAATTCACCTTCACCCCCAGG
The PCR mixture consisted of approximately 135 ngµL−1 of wild-type
TmaDAH7PS plasmid DNA, 0.5µM of both primers, 200 µM of each of the
deoxyribonucleotide triphosphates (dNTPs), 1× Phusion® HF buffer and
0.01U of Phusion® DNA polymerase in a total reaction volume of 50 µL. The
thermo-cycling program consisted of an initial denaturation at 98℃ for 1min
and this was followed by 31 cycles of denaturation for 10 s, primer annealing
at 63℃ for 30 s with extension at 72℃ for 30 s. The 807 base pair (bp) PCR
product was subjected to Dpn1 treatment (0.5µL per 25µL PCR reaction for
one hour at 37℃, purified by E-Gel® CloneWell™ agarose gel electrophoresis
and further purified and concentrated using a DNA Clean and Concentrator
Kit™ (Zymo Research Corporation).
8.3.2 Transformation into E. coli One Shot® TOP10
Chemically Competent Cells
The 807 bp PCR product encoding truncTmaDAH7PS was ligated into a
pENTR™/TEV/dTOPO vector using Gateway® cloning technology. Fresh
PCR product (approximately 150 ng) was combined with 1µL of the salt
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solution (1.2M NaCl and 0.06µM MgCl2), and 1µL of the TOPO® pENTR™/
TEV/dTOPO vector (15 ngµL−1 to 20 ng µL−1 linearised plasmid DNA) in
50% glycerol, 50mM Tris-HCl, pH 7.4, 1mM EDTA, 2mM DTT, 0.1%
Triton X-100, 100 ngmL−1 bovine serum albumin (BSA), 30µM bromophenol
blue) to a final reaction volume of 6 µL, mixed gently and incubated for 5min
at room temperature.
The ligation mixture was used to transform competent E. coli One Shot®
TOP10 Chemically Competent cells (Invitrogen). 50µL of competent cells
were thawed and incubated on ice for 15min with 2µL of ligation mixture.
The cells were then heat shocked at 42℃ for 30 s and then returned to ice
before 250 µL of room temperature SOC was added. The cells were incubated
at 37℃ for 1 hr with shaking. The cells were plated onto prewarmed LB
plates containing Kan and left to grow overnight at 37℃.
Plasmid DNA was isolated from 5mL cultures in LB containing Kan
using a High Pure Plasmid Isolation Kit (Roche). Colony PCR was used to
identify colonies containing inserts in the correct orientation and the correct
number of bps. The PCR reaction consisted of 1× PCR buffer, 200µM of each
dNTP, 1.5mM MgCl2, 0.5µM of both primers (one corresponding to the gene
and the other to the plasmid), 1U Taq DNA polymerase (Invitrogen) and
approximately 50 ng of the plasmid extracted from each colony. Each PCR
product that showed amplification of the approximate bp size of truncTma-
DAH7PS was DNA sequenced to identify a clone in which the insert PCR
in the recombinant plasmid was identical to the expected ORF for truncTma-
DAH7PS.
8.3.3 LR Recombination Reaction and Vector Shuffle
into pDEST566
A sequenced pENTR™/TEV/dTOPO truncTmaDAH7PS plasmid was used
to perform the Gateway® LR recombination reaction and pDEST566, MBP-
tagged, or pDEST15, His-tag destination vectors used.
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8.3.4 Purification using MBP Affinity
Chromatography
The supernatant collected after cell lysis and centrifugation was applied to
a MBP-Trap (GE Healthcare) pre-equilibrated with Buffer A (10mM BTP,
pH 7.5, 1mM EDTA, 100mM KCl, 200 µM PEP) and eluted using Buffer C
(Buffer A + 10mM maltose). Fractions containing truncTmaDAH7PS were
pooled and concentrated using a 20mL 10 kDa MWCO device (Sartorius
Stedim Biotech) and desalted. The MBP was cleaved from the truncTma-
DAH7PS using TEV protease (4mg) and left stirring overnight at room
temperature. The resulting supernatant was heat treated in covered Corex
tubes at 60℃ for 40min and left on the bench to cool to room temperature.
Precipitated protein was removed by centrifugation at 24,000 g for 30min at
4℃. The supernatant was reapplied to MB-Trap (GE Healthcare) equilib-
rated with Buffer A, eluted in the flow through, concentrated using a 20mL
10 kDa MWCO device (Vivascience), loaded to a 26/60 SEC column (GE
Healthcare) and eluted using Buffer A at a flow rate of 2mLmin−1. Frac-
tions containing truncTmaDAH7PS were pooled, concentrated and reloaded to
a pre-equilibrated (Buffer A) MBP-Trap and eluted in the flow through to
remove any remaining cleaved MBP-tag. Again, fractions containing truncTma-
DAH7PS were pooled, concentrated using a 20mL 10 kDa MWCO device
(Vivascience).
8.3.5 Kinetic Parameters
The assays for determining the kinetic parameters for truncTmaDAH7PS
included 100 µM MnSO4, 2 µL 0.84mgmL−1 enzyme in 50mM BTP, pH
7.3 buffer. To determine the KE4Pm , the PEP concentration was fixed at
80 µM while the E4P concentration was varied (20 µM to 310 µM). For the
determination of KPEPm , E4P concentration was fixed at 310µM while the
PEP concentration was varied (10 µM to 165 µM).
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8.3.6 Metal Activation
The metal activation profile of truncTmaDAH7PS was determined using stand-
ard assays with 123µM PEP and 309 µM E4P in 50mM BTP pH 7.3, con-
taining 20 µM EDTA at 60℃ and 100 µM of CoCl2, CdCl2, ZnCl2 or MnSO4
made up in Chelexed and filtered Milli-Q. The enzyme (2µL 0.83mgmL−1)
was incubated with the metal ion for 2min prior to activation with E4P, to a
final volume of 1mL. Triplicate assays were performed.
8.3.7 Response to Allosteric Effectors
Reactions were carried out as per wild-type (refer to General Methods, Section
8.1.35), however 2µL of 2.94mgmL−1 purified enzyme was used.
8.3.8 Crystallisation Trials
Initial screens of truncTmaDAH7PS were set up using the sitting-drop vapour
diffusion method with droplets of protein solution (0.15µL, 5mg mL−1 in
10mM BTP, 100mM KCl, 200 µM PEP, pH 7.5) and reservoir solution
(0.15µL).
8.4 Methods for Chapter Four
8.4.1 Crystallisation Trials
For crystallisation trials of TmaDAH7PS with Tyr, initial screens were set up
with droplets of 0.15 µL of protein solution (10mg mL−1 in 10mM BTP, pH
7.5, 100mM KCl, 200 µM PEP and 1mM Tyr) and 0.15 µL reservoir solution.
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8.5 Methods for Chapter Five
8.5.1 Site-Directed Mutagenesis
The H29A, S31G and H29S/S31H mutations were performed using the Quik-
Change® Lightning Site-Directed Mutagenesis Kit (Stratagene), and pT7-7
TmaDAH7PS as the double stranded plasmid template. The single amino
acid substitutions (either His-to-Ala, Ser-to-Gly or His-to-Ser and Ser-to-His)
were introduced using synthetic oligonucleotide primers, each complementary
to opposite strands of pT7-7 TmaDAH7PS, containing the desired mutation.
For the primers shown below, codons representing the mutation are shown in
lower-case letters.
TmaH29A
For: 5’ GAGAGTTACAACTTGAAGTGTgccATTTCCAAAGGTCAGGAAAG
Rev: 5’ CTTTCCTGACCTTTGGAAATggcACACTTCAAGTTGTAACTCTC
TmaS31G
For: 5’ ACAACTTGAAGTGTCACATTggcAAAGGTCAGGAAAGAACGG
Rev: 5’ CCGTTCTTTCCTGACCTTTgccAAAGGTCAGGAAAGAACGG
TmaH29S/S31H
For: 5’ GGCCGAGAGTTACAACTTGAAGTGTagcATTcacAAAGGTCAGGAAAGAACGGTTATT
Rev: 5’ AATAACCGTTCTTTCCTGACCTTTgtgAATgctACACTTCAAGTTGTAACTCTCGGCC
The procedure included three steps (as described in the QuikChange®
manual): the primers with the desired mutation were extended during temper-
ature cycling by a derivative of PfuUltra® high-fidelity (HF) DNA polymerase,
generating a mutated plasmid containing staggered nicks. Following temper-
ature cycling, the product was treated with DpnI to digest the parental DNA
template. The nicked vector DNA containing the desired mutations was then
transformed into One Shot® TOP10 competent cells (Invitrogen). Plasmid
mini-prep DNA was then isolated from transformants using a High Pure
Plasmid Isolation Kit (Roche) and the insert DNA sequenced to verify the
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correct sequence before the plasmid-mutant construct was used to transform
E. coli BL21(DE3) Star cells (Invitrogen).
8.5.2 Kinetic Parameters
Assays used to determine the kinetic parameters of all mutants of Tma-
DAH7PS contained 100 µM MnSO4, 2 µL of 0.52mgmL−1 to 1.2mgmL−1
enzyme in 50mM BTP, pH 7.3 buffer. To determine the KE4Pm , the PEP
concentration was fixed at 80µM (except for H29S/S31H for which PEP was
fixed at 200 µM because of the higher PEP Km), while the E4P concentration
was varied (11 µM to 220 µM). For determination KPEPm , E4P concentration
was fixed at 160 µM while the PEP concentration was varied (10 µM to
200 µM).
8.5.3 Response to Inhibitors
The assay mixtures to determine the effect of Tyr and Phe on the activity
of the variants contained PEP (120 µM to 200 µM), E4P (200 µM to 220 µM
and MnSO4 (100µM) in 50mM BTP, pH 7.3. Reaction mixtures have either
no amino acids or 0mM to 1mM Tyr or Phe. The reactions were performed
as for standard assays and triplicate assays were performed for all reaction
conditions.
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8.6 Methods for Chapter Six
8.6.1 Ligation of TmaPfuDAH7PS into pDEST14
A synthetic gene encoding for the ORF of TmaPfuDAH7PS was ordered from
GeneART® (Life Technologies). The synthetic gene had been optimised for
expression in E. coli, inserted into the recombinational cloning entry vector
pENTR221 and DNA sequenced before arrival. The TmaPfuDAH7PS gene
was then ligated into the untagged Gateway expression vector pDEST14
using LR clonase II enzyme mix (Invitrogen) using Gateway Technology (as
described in General Methods, Section 8.1.7). The reaction mixture was used
to transform competent E. coli One Shot TOP10 and BL21(DE3) Star cells
(Invitrogen).
8.6.2 Circular Dichroism Spectroscopy
CD spectroscopy experiments were performed using a JASCO J-815 Spec-
tropolarimeter and spectra recorded from 260 nm to 190 nm using a 0.5 nm
data pitch, 1 s response, 1 nm bandwidth at 25℃. A 2mL protein solution at
a concentration of 0.03mgmL−1 in a 3mL quartz cuvette with a 1 cm path
length was used. The buffer used was 10mM phosphate, pH 7.0. A blank
spectra of only buffer was recorded before the addition of protein.
The thermal denaturation was measured at 220 nm where a shift in the
CD-spectrum indicative of the α-helix occurs. The CD was recorded every
2℃ while heating from 25℃ to 90℃ in a stopped cuvette, and the melt
temperatures were calculated as the temperature of maximum inflection of
the melting curve.
The Savitzky-Golay algorithm of the Lasco Spectra Manager™ (version
1.5) with a convolution width of 15 was used to smooth data.
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8.6.3 Kinetic Parameters
To determine KE4Pm , 100µM MnSO4, 240µM PEP in 50mM BTP, pH 7.3 was
used with 2 µL of 2.03mgmL−1 enzyme. E4P was varied between 28 µM and
440 µM.
For KPEPm , reaction mixtures contained 100 µM MnSO4, 330µM E4P,
enzyme (2µL, 2.03mgmL−1) in 50mM BTP, pH 7.3, and between 10 µM and
400 µM PEP.
For the determination of KE4Pm in the presence of Tyr, 300µM PEP,
100µM MnSO4 and 2 µL at 6.2mgmL−1 in 50mM BTP pH 7.3 and 500 µM
Tyr were held constant while E4P concentration was varied between 11 µM
and 220 µM.
66µM E4P, 100 µM MnSO4 and 2 µL at 6.2mgmL−1 enzyme in 50mM
BTP pH 7.3 and 500µM were used to determine KPEPm in the presence of Tyr,
whereas the concentration of PEP was varied between 40 µM and 400µM.
8.6.4 Response to Allosteric Effectors
The response of the catalytic activity of TmaPfuDAH7PS was determined in the
presence of 300 µM PEP, 100 µM MnSO4, 110 µM E4P and 2µL 6.2mgmL−1
enzyme in 50mM BTP, pH 7.3 and 0mM to 1mM of either Tyr or Phe.
Triplicate assays were performed and averaged.
Appendices
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Appendix A
Chapter Two Michaelis-Menten
Plots For Determination of Km
Values Calculated for
TmaDAH7PS
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(a) (b)
(c) (d)
Figure A.1: Michaelis-Menten plots used for determination of the Km values
of both (a) PEP and (b) E4P for TmaDAH7PS, and (c) and (d), Michaelis-
Menten plots used to ascertain the values for PEP and E4P in the presence of
Tyr, respectively. Km and kcat values were determined by fitting the data to the
Michaelis-Menten equation using Grafit (Erithacus Software).
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Appendix B
Chapter Three
Michaelis-Menten Plots For
Determination of Km Values
Calculated for
truncTmaDAH7PS
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(a) (b)
Figure B.1: Michaelis-Menten plots used for determination of the Km values
of both (a) PEP and (b) E4P for truncTmaDAH7PS. Km and kcat values were
determined by fitting the data to the Michaelis-Menten equation using Grafit
(Erithacus Software).
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Chapter Five Guinier Plots and
P(r) Functions Calculated
From TmaDAH7PS Mutant
SAXS Data
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(a) (b)
(c) (d)
(e) (f)
Figure C.1: Guinier plots and P(r) functions calculated using GNOM from
TmaDAH7PS SAXS data in the (a and b) absence of inhibitor, presence of (c and
d) 1mM Tyr and (e and f) 1mM Phe. Uncertainty in P(r) propagated from the
I (s) vs s profile is indicated by error bars.
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(a) (b)
(c) (d)
(e) (f)
Figure C.2: Guinier plots and P(r) functions calculated using GNOM from
TmaH29A SAXS data in the (a and b) absence of inhibitor, presence of (c and d)
1mM Tyr and (e and f) 1mM Phe. Uncertainty in P(r) propagated from the I (s)
vs s profile is indicated by error bars.
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(a) (b)
(c) (d)
(e) (f)
Figure C.3: Guinier plots and P(r) functions calculated using GNOM from
TmaS31G SAXS data in the (a and b) absence of inhibitor, presence of (c and d)
1mM Tyr and (e and f) 1mM Phe. Uncertainty in P(r) propagated from the I (s)
vs s profile is indicated by error bars.
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(a) (b)
(c) (d)
(e) (f)
Figure C.4: Guinier plots and P(r) functions calculated using GNOM from
TmaH29SS31H SAXS data in the (a and b) absence of inhibitor, presence of (c and
d) 1mM Tyr and (e and f) 1mM Phe. Uncertainty in P(r) propogated from the
I (s) vs s profile is indicated by error bars.
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Chapter Six Codon Optimised
Nucleotide Sequence of
TmaPfuDAH7PS
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Figure D.1: Nucleotide sequence of the codon optimised TmaPfuDAH7PS.
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The first step of the shikimate pathway for aromatic amino 
acid biosynthesis is catalyzed by 3-deoxy-D-arabino-heptulosonate 
7-phosphate synthase (DAH7PS). Thermotoga maritima 
DAH7PS (TmaDAH7PS) is tetrameric, with monomer 
units comprised of a core catalytic (_/_)8 barrel and an N-terminal 
domain. This enzyme is inhibited strongly by tyrosine and 
to a lesser extent by the presence of phenylalanine. A truncated 
mutant of TmaDAH7PS lacking the N-terminal domain was 
catalytically more active and completely insensitive to tyrosine 
and phenylalanine, consistent with a role for this domain in allosteric 
inhibition. The structure of this protein was determined 
to 2.0 A˚ . In contrast to the wild-type enzyme, this enzyme is 
dimeric. Wild-type TmaDAH7PS was co-crystallized with tyrosine, 
and the structure of this complex was determined to a resolution 
of 2.35 A˚ . Tyrosine was found to bind at the interface 
between two regulatory N-terminal domains, formed from diagonally 
located monomers of the tetramer, revealing a major 
reorganization of the regulatory domain with respect to the barrel 
relative to unliganded enzyme. This significant conformational 
rearrangement observed in the crystal structures was also 
clearly evident from small angle X-ray scattering measurements 
recorded in the presence and absence of tyrosine. The closed 
conformation adopted by the protein on tyrosine binding 
impedes substrate entry into the neighboring barrel, revealing 
an unusual tyrosine-controlled gating mechanism for allosteric 
control of this enzyme. 
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